TP53,tumor protein p53,360 / 986 (36.51%),"4,008 / 10,202","16 / 1,072 (1.49%)","47 / 1,072 (4.38%)",240,Cancer Gene Census,add to survival plot
PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",339 / 986 (34.38%),"1,403 / 10,202","151 / 1,072 (14.09%)","15 / 1,072 (1.40%)",82,Cancer Gene Census,add to survival plot
TTN,titin,243 / 986 (24.65%),"3,858 / 10,202","45 / 1,072 (4.20%)","22 / 1,072 (2.05%)",472,,add to survival plot
MUC4,"mucin 4, cell surface associated",197 / 986 (19.98%),"1,304 / 10,202","135 / 1,072 (12.59%)","27 / 1,072 (2.52%)",141,,add to survival plot
MUC16,"mucin 16, cell surface associated",149 / 986 (15.11%),"2,466 / 10,202","54 / 1,072 (5.04%)","51 / 1,072 (4.76%)",204,,add to survival plot
CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",149 / 986 (15.11%),"385 / 10,202","36 / 1,072 (3.36%)","46 / 1,072 (4.29%)",133,Cancer Gene Census,add to survival plot
GATA3,GATA binding protein 3,141 / 986 (14.30%),"362 / 10,202","113 / 1,072 (10.54%)","10 / 1,072 (0.93%)",107,Cancer Gene Census,add to survival plot
MUC2,"mucin 2, oligomeric mucus/gel-forming",114 / 986 (11.56%),"699 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",58,,add to survival plot
KMT2C,lysine (K)-specific methyltransferase 2C,101 / 986 (10.24%),"1,003 / 10,202","51 / 1,072 (4.76%)","97 / 1,072 (9.05%)",128,Cancer Gene Census,add to survival plot
MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase",91 / 986 (9.23%),"328 / 10,202","22 / 1,072 (2.05%)","79 / 1,072 (7.37%)",134,Cancer Gene Census,add to survival plot
RYR2,ryanodine receptor 2 (cardiac),89 / 986 (9.03%),"1,575 / 10,202","166 / 1,072 (15.49%)","34 / 1,072 (3.17%)",0,,add to survival plot
SYNE1,"spectrin repeat containing, nuclear envelope 1",81 / 986 (8.22%),"1,593 / 10,202","73 / 1,072 (6.81%)","78 / 1,072 (7.28%)",0,,add to survival plot
HMCN1,hemicentin 1,79 / 986 (8.01%),"1,148 / 10,202","125 / 1,072 (11.66%)","23 / 1,072 (2.15%)",0,,add to survival plot
USH2A,"Usher syndrome 2A (autosomal recessive, mild)",77 / 986 (7.81%),"1,393 / 10,202","144 / 1,072 (13.43%)","30 / 1,072 (2.80%)",0,,add to survival plot
SPTA1,"spectrin, alpha, erythrocytic 1",74 / 986 (7.51%),"1,126 / 10,202","141 / 1,072 (13.15%)","27 / 1,072 (2.52%)",0,,add to survival plot
FLG,filaggrin,71 / 986 (7.20%),"1,430 / 10,202","179 / 1,072 (16.70%)","19 / 1,072 (1.77%)",0,,add to survival plot
DST,dystonin,69 / 986 (7.00%),"1,181 / 10,202","82 / 1,072 (7.65%)","32 / 1,072 (2.99%)",0,,add to survival plot
RYR3,ryanodine receptor 3,69 / 986 (7.00%),"1,075 / 10,202","33 / 1,072 (3.08%)","97 / 1,072 (9.05%)",0,,add to survival plot
PTEN,phosphatase and tensin homolog,68 / 986 (6.90%),"1,005 / 10,202","30 / 1,072 (2.80%)","116 / 1,072 (10.82%)",0,Cancer Gene Census,add to survival plot
ZFHX4,zinc finger homeobox 4,64 / 986 (6.49%),"1,293 / 10,202","106 / 1,072 (9.89%)","40 / 1,072 (3.73%)",0,,add to survival plot
DMD,dystrophin,64 / 986 (6.49%),"952 / 10,202","41 / 1,072 (3.82%)","32 / 1,072 (2.99%)",0,,add to survival plot
OBSCN,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF",63 / 986 (6.39%),"1,316 / 10,202","158 / 1,072 (14.74%)","25 / 1,072 (2.33%)",0,,add to survival plot
NEB,nebulin,61 / 986 (6.19%),"1,040 / 10,202","19 / 1,072 (1.77%)","37 / 1,072 (3.45%)",0,,add to survival plot
MUC17,"mucin 17, cell surface associated",59 / 986 (5.98%),"1,105 / 10,202","31 / 1,072 (2.89%)","37 / 1,072 (3.45%)",0,,add to survival plot
MACF1,microtubule-actin crosslinking factor 1,58 / 986 (5.88%),"1,050 / 10,202","73 / 1,072 (6.81%)","44 / 1,072 (4.10%)",0,,add to survival plot
SYNE2,"spectrin repeat containing, nuclear envelope 2",57 / 986 (5.78%),"897 / 10,202","42 / 1,072 (3.92%)","62 / 1,072 (5.78%)",0,,add to survival plot
NCOR1,nuclear receptor corepressor 1,57 / 986 (5.78%),"505 / 10,202","25 / 1,072 (2.33%)","34 / 1,072 (3.17%)",0,Cancer Gene Census,add to survival plot
APOB,apolipoprotein B,56 / 986 (5.68%),"1,092 / 10,202","33 / 1,072 (3.08%)","39 / 1,072 (3.64%)",0,,add to survival plot
NF1,neurofibromin 1,55 / 986 (5.58%),"776 / 10,202","93 / 1,072 (8.68%)","65 / 1,072 (6.06%)",0,Cancer Gene Census,add to survival plot
MUC5B,"mucin 5B, oligomeric mucus/gel-forming",54 / 986 (5.48%),"981 / 10,202","35 / 1,072 (3.26%)","85 / 1,072 (7.93%)",0,,add to survival plot
PKHD1L1,polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1,54 / 986 (5.48%),"947 / 10,202","191 / 1,072 (17.82%)","12 / 1,072 (1.12%)",0,,add to survival plot
GOLGA6L6,golgin A6 family-like 6,53 / 986 (5.38%),"254 / 10,202","52 / 1,072 (4.85%)","100 / 1,072 (9.33%)",0,,add to survival plot
ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13",53 / 986 (5.38%),"958 / 10,202","41 / 1,072 (3.82%)","22 / 1,072 (2.05%)",0,,add to survival plot
CSMD1,CUB and Sushi multiple domains 1,53 / 986 (5.38%),"1,188 / 10,202","52 / 1,072 (4.85%)","142 / 1,072 (13.25%)",0,,add to survival plot
CCDC168,coiled-coil domain containing 168,52 / 986 (5.27%),"362 / 10,202","95 / 1,072 (8.86%)","17 / 1,072 (1.59%)",0,,add to survival plot
CSMD3,CUB and Sushi multiple domains 3,51 / 986 (5.17%),"1,636 / 10,202","218 / 1,072 (20.34%)","15 / 1,072 (1.40%)",0,,add to survival plot
FAT3,FAT atypical cadherin 3,51 / 986 (5.17%),"1,170 / 10,202","74 / 1,072 (6.90%)","85 / 1,072 (7.93%)",0,,add to survival plot
RUNX1,runt-related transcription factor 1,50 / 986 (5.07%),"233 / 10,202","92 / 1,072 (8.58%)","32 / 1,072 (2.99%)",0,Cancer Gene Census,add to survival plot
DNAH11,"dynein, axonemal, heavy chain 11",49 / 986 (4.97%),"942 / 10,202","52 / 1,072 (4.85%)","34 / 1,072 (3.17%)",0,,add to survival plot
RYR1,ryanodine receptor 1 (skeletal),49 / 986 (4.97%),"1,090 / 10,202","65 / 1,072 (6.06%)","29 / 1,072 (2.71%)",0,,add to survival plot
HUWE1,"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase",49 / 986 (4.97%),"726 / 10,202","41 / 1,072 (3.82%)","12 / 1,072 (1.12%)",0,,add to survival plot
CACNA1E,"calcium channel, voltage-dependent, R type, alpha 1E subunit",47 / 986 (4.77%),"846 / 10,202","109 / 1,072 (10.17%)","28 / 1,072 (2.61%)",0,,add to survival plot
XIRP2,xin actin-binding repeat containing 2,47 / 986 (4.77%),"1,185 / 10,202","36 / 1,072 (3.36%)","25 / 1,072 (2.33%)",0,,add to survival plot
PCLO,piccolo presynaptic cytomatrix protein,47 / 986 (4.77%),"1,340 / 10,202","36 / 1,072 (3.36%)","30 / 1,072 (2.80%)",0,,add to survival plot
LRP1B,low density lipoprotein receptor-related protein 1B,47 / 986 (4.77%),"1,524 / 10,202","42 / 1,072 (3.92%)","67 / 1,072 (6.25%)",0,,add to survival plot
ARID1A,AT rich interactive domain 1A (SWI-like),46 / 986 (4.67%),"936 / 10,202","19 / 1,072 (1.77%)","173 / 1,072 (16.14%)",0,Cancer Gene Census,add to survival plot
PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",45 / 986 (4.56%),"540 / 10,202","13 / 1,072 (1.21%)","77 / 1,072 (7.18%)",0,Cancer Gene Census,add to survival plot
LRP2,low density lipoprotein receptor-related protein 2,45 / 986 (4.56%),"1,009 / 10,202","45 / 1,072 (4.20%)","24 / 1,072 (2.24%)",0,,add to survival plot
ADGRV1,adhesion G protein-coupled receptor V1,44 / 986 (4.46%),"1,005 / 10,202","15 / 1,072 (1.40%)","58 / 1,072 (5.41%)",0,,add to survival plot
MAP2K4,mitogen-activated protein kinase kinase 4,44 / 986 (4.46%),"206 / 10,202","10 / 1,072 (0.93%)","59 / 1,072 (5.50%)",0,Cancer Gene Census,add to survival plot
RNF213,ring finger protein 213,44 / 986 (4.46%),"755 / 10,202","212 / 1,072 (19.78%)","33 / 1,072 (3.08%)",0,Cancer Gene Census,add to survival plot
DNAH17,"dynein, axonemal, heavy chain 17",44 / 986 (4.46%),"820 / 10,202","215 / 1,072 (20.06%)","28 / 1,072 (2.61%)",0,,add to survival plot
HYDIN,"HYDIN, axonemal central pair apparatus protein",43 / 986 (4.36%),"870 / 10,202","36 / 1,072 (3.36%)","42 / 1,072 (3.92%)",0,,add to survival plot
MDN1,"MDN1, midasin homolog (yeast)",43 / 986 (4.36%),"707 / 10,202","35 / 1,072 (3.26%)","81 / 1,072 (7.56%)",0,,add to survival plot
CSMD2,CUB and Sushi multiple domains 2,43 / 986 (4.36%),"969 / 10,202","44 / 1,072 (4.10%)","85 / 1,072 (7.93%)",0,,add to survival plot
SPEN,spen family transcriptional repressor,43 / 986 (4.36%),"596 / 10,202","17 / 1,072 (1.59%)","184 / 1,072 (17.16%)",0,Cancer Gene Census,add to survival plot
DCHS2,dachsous cadherin-related 2,43 / 986 (4.36%),"741 / 10,202","48 / 1,072 (4.48%)","44 / 1,072 (4.10%)",0,,add to survival plot
KMT2D,lysine (K)-specific methyltransferase 2D,43 / 986 (4.36%),"1,140 / 10,202","42 / 1,072 (3.92%)","45 / 1,072 (4.20%)",0,Cancer Gene Census,add to survival plot
PRUNE2,prune homolog 2 (Drosophila),42 / 986 (4.26%),"658 / 10,202","29 / 1,072 (2.71%)","35 / 1,072 (3.26%)",0,,add to survival plot
AHNAK,AHNAK nucleoprotein,41 / 986 (4.16%),"855 / 10,202","106 / 1,072 (9.89%)","49 / 1,072 (4.57%)",0,,add to survival plot
PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",41 / 986 (4.16%),"650 / 10,202","113 / 1,072 (10.54%)","67 / 1,072 (6.25%)",0,,add to survival plot
AHNAK2,AHNAK nucleoprotein 2,41 / 986 (4.16%),"1,019 / 10,202","69 / 1,072 (6.44%)","56 / 1,072 (5.22%)",0,,add to survival plot
MXRA5,matrix-remodelling associated 5,41 / 986 (4.16%),"778 / 10,202","46 / 1,072 (4.29%)","31 / 1,072 (2.89%)",0,,add to survival plot
DNAH8,"dynein, axonemal, heavy chain 8",40 / 986 (4.06%),"985 / 10,202","72 / 1,072 (6.72%)","32 / 1,072 (2.99%)",0,,add to survival plot
SVEP1,"sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1",40 / 986 (4.06%),"663 / 10,202","30 / 1,072 (2.80%)","40 / 1,072 (3.73%)",0,,add to survival plot
AKAP9,A kinase (PRKA) anchor protein 9,40 / 986 (4.06%),"618 / 10,202","42 / 1,072 (3.92%)","26 / 1,072 (2.43%)",0,Cancer Gene Census,add to survival plot
TENM1,teneurin transmembrane protein 1,40 / 986 (4.06%),"810 / 10,202","35 / 1,072 (3.26%)","23 / 1,072 (2.15%)",0,,add to survival plot
BIRC6,baculoviral IAP repeat containing 6,40 / 986 (4.06%),"688 / 10,202","46 / 1,072 (4.29%)","22 / 1,072 (2.05%)",0,,add to survival plot
FAT1,FAT atypical cadherin 1,40 / 986 (4.06%),"875 / 10,202","53 / 1,072 (4.94%)","74 / 1,072 (6.90%)",0,Cancer Gene Census,add to survival plot
XKR4,"XK, Kell blood group complex subunit-related family, member 4",40 / 986 (4.06%),"648 / 10,202","91 / 1,072 (8.49%)","67 / 1,072 (6.25%)",0,,add to survival plot
ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",40 / 986 (4.06%),"622 / 10,202","129 / 1,072 (12.03%)","17 / 1,072 (1.59%)",0,,add to survival plot
MYH9,"myosin, heavy chain 9, non-muscle",39 / 986 (3.96%),"455 / 10,202","24 / 1,072 (2.24%)","35 / 1,072 (3.26%)",0,Cancer Gene Census,add to survival plot
CHD6,chromodomain helicase DNA binding protein 6,39 / 986 (3.96%),"546 / 10,202","54 / 1,072 (5.04%)","48 / 1,072 (4.48%)",0,,add to survival plot
DNAH9,"dynein, axonemal, heavy chain 9",39 / 986 (3.96%),"994 / 10,202","13 / 1,072 (1.21%)","46 / 1,072 (4.29%)",0,,add to survival plot
GON4L,gon-4-like (C. elegans),39 / 986 (3.96%),"480 / 10,202","156 / 1,072 (14.55%)","27 / 1,072 (2.52%)",0,,add to survival plot
SACS,sacsin molecular chaperone,39 / 986 (3.96%),"769 / 10,202","86 / 1,072 (8.02%)","73 / 1,072 (6.81%)",0,,add to survival plot
ASH1L,"ash1 (absent, small, or homeotic)-like (Drosophila)",38 / 986 (3.85%),"594 / 10,202","168 / 1,072 (15.67%)","26 / 1,072 (2.43%)",0,,add to survival plot
DNAH3,"dynein, axonemal, heavy chain 3",38 / 986 (3.85%),"884 / 10,202","40 / 1,072 (3.73%)","13 / 1,072 (1.21%)",0,,add to survival plot
FMN2,formin 2,38 / 986 (3.85%),"731 / 10,202","162 / 1,072 (15.11%)","39 / 1,072 (3.64%)",0,,add to survival plot
LYST,lysosomal trafficking regulator,38 / 986 (3.85%),"602 / 10,202","171 / 1,072 (15.95%)","34 / 1,072 (3.17%)",0,,add to survival plot
DNM1P47,DNM1 pseudogene 47,38 / 986 (3.85%),"444 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",0,,add to survival plot
CUBN,cubilin (intrinsic factor-cobalamin receptor),38 / 986 (3.85%),"836 / 10,202","72 / 1,072 (6.72%)","15 / 1,072 (1.40%)",0,,add to survival plot
DNAH14,"dynein, axonemal, heavy chain 14",38 / 986 (3.85%),"327 / 10,202","160 / 1,072 (14.93%)","22 / 1,072 (2.05%)",0,,add to survival plot
ST6GALNAC3,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3",38 / 986 (3.85%),"269 / 10,202","49 / 1,072 (4.57%)","64 / 1,072 (5.97%)",0,,add to survival plot
DNAH5,"dynein, axonemal, heavy chain 5",38 / 986 (3.85%),"1,258 / 10,202","84 / 1,072 (7.84%)","12 / 1,072 (1.12%)",0,,add to survival plot
LAMA1,"laminin, alpha 1",38 / 986 (3.85%),"753 / 10,202","24 / 1,072 (2.24%)","29 / 1,072 (2.71%)",0,,add to survival plot
NBPF12,"neuroblastoma breakpoint family, member 12",38 / 986 (3.85%),"307 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",0,,add to survival plot
RELN,reelin,38 / 986 (3.85%),"859 / 10,202","30 / 1,072 (2.80%)","43 / 1,072 (4.01%)",0,,add to survival plot
USP34,ubiquitin specific peptidase 34,37 / 986 (3.75%),"498 / 10,202","62 / 1,072 (5.78%)","10 / 1,072 (0.93%)",0,,add to survival plot
TBX3,T-box 3,37 / 986 (3.75%),"263 / 10,202","26 / 1,072 (2.43%)","88 / 1,072 (8.21%)",0,Cancer Gene Census,add to survival plot
VPS13B,vacuolar protein sorting 13 homolog B (yeast),37 / 986 (3.75%),"728 / 10,202","203 / 1,072 (18.94%)","23 / 1,072 (2.15%)",0,,add to survival plot
LRP1,low density lipoprotein receptor-related protein 1,37 / 986 (3.75%),"738 / 10,202","36 / 1,072 (3.36%)","36 / 1,072 (3.36%)",0,,add to survival plot
ALMS1,Alstrom syndrome 1,37 / 986 (3.75%),"637 / 10,202","45 / 1,072 (4.20%)","13 / 1,072 (1.21%)",0,,add to survival plot
MED12,mediator complex subunit 12,37 / 986 (3.75%),"477 / 10,202","24 / 1,072 (2.24%)","20 / 1,072 (1.87%)",0,Cancer Gene Census,add to survival plot
HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,37 / 986 (3.75%),"788 / 10,202","42 / 1,072 (3.92%)","106 / 1,072 (9.89%)",0,,add to survival plot
ANK2,"ankyrin 2, neuronal",36 / 986 (3.65%),"879 / 10,202","42 / 1,072 (3.92%)","40 / 1,072 (3.73%)",0,,add to survival plot
KMT2A,lysine (K)-specific methyltransferase 2A,36 / 986 (3.65%),"602 / 10,202","28 / 1,072 (2.61%)","163 / 1,072 (15.21%)",0,Cancer Gene Census,add to survival plot
FCGBP,Fc fragment of IgG binding protein,36 / 986 (3.65%),"830 / 10,202","61 / 1,072 (5.69%)","31 / 1,072 (2.89%)",0,,add to survival plot
PTPRD,"protein tyrosine phosphatase, receptor type, D",36 / 986 (3.65%),"696 / 10,202","70 / 1,072 (6.53%)","73 / 1,072 (6.81%)",0,,add to survival plot
ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",36 / 986 (3.65%),"829 / 10,202","70 / 1,072 (6.53%)","32 / 1,072 (2.99%)",0,,add to survival plot
SRCAP,Snf2-related CREBBP activator protein,36 / 986 (3.65%),"578 / 10,202","67 / 1,072 (6.25%)","10 / 1,072 (0.93%)",40,,add to survival plot
MLLT4,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4",36 / 986 (3.65%),"439 / 10,202","61 / 1,072 (5.69%)","111 / 1,072 (10.35%)",33,Cancer Gene Census,add to survival plot
CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",35 / 986 (3.55%),"698 / 10,202","85 / 1,072 (7.93%)","49 / 1,072 (4.57%)",36,,add to survival plot
FBN1,fibrillin 1,35 / 986 (3.55%),"554 / 10,202","28 / 1,072 (2.61%)","81 / 1,072 (7.56%)",40,,add to survival plot
CDH23,cadherin-related 23,35 / 986 (3.55%),"640 / 10,202","58 / 1,072 (5.41%)","29 / 1,072 (2.71%)",36,,add to survival plot
KIAA2022,KIAA2022,35 / 986 (3.55%),"586 / 10,202","12 / 1,072 (1.12%)","26 / 1,072 (2.43%)",36,,add to survival plot
KIAA1109,KIAA1109,35 / 986 (3.55%),"715 / 10,202","45 / 1,072 (4.20%)","31 / 1,072 (2.89%)",41,,add to survival plot
UTRN,utrophin,35 / 986 (3.55%),"551 / 10,202","72 / 1,072 (6.72%)","65 / 1,072 (6.06%)",39,,add to survival plot
DNAH10,"dynein, axonemal, heavy chain 10",35 / 986 (3.55%),"777 / 10,202","41 / 1,072 (3.82%)","85 / 1,072 (7.93%)",47,,add to survival plot
COL6A5,"collagen, type VI, alpha 5",35 / 986 (3.55%),"413 / 10,202","43 / 1,072 (4.01%)","38 / 1,072 (3.54%)",41,,add to survival plot
TG,thyroglobulin,35 / 986 (3.55%),"725 / 10,202","192 / 1,072 (17.91%)","43 / 1,072 (4.01%)",38,,add to survival plot
MYCBP2,"MYC binding protein 2, E3 ubiquitin protein ligase",35 / 986 (3.55%),"621 / 10,202","61 / 1,072 (5.69%)","34 / 1,072 (3.17%)",43,,add to survival plot
ATRX,alpha thalassemia/mental retardation syndrome X-linked,34 / 986 (3.45%),"795 / 10,202","18 / 1,072 (1.68%)","21 / 1,072 (1.96%)",54,Cancer Gene Census,add to survival plot
FOXA1,forkhead box A1,34 / 986 (3.45%),"204 / 10,202","116 / 1,072 (10.82%)","15 / 1,072 (1.40%)",36,Cancer Gene Census,add to survival plot
UBR4,ubiquitin protein ligase E3 component n-recognin 4,34 / 986 (3.45%),"708 / 10,202","19 / 1,072 (1.77%)","182 / 1,072 (16.98%)",44,,add to survival plot
DNAH6,"dynein, axonemal, heavy chain 6",34 / 986 (3.45%),"364 / 10,202","56 / 1,072 (5.22%)","17 / 1,072 (1.59%)",45,,add to survival plot
PTPRB,"protein tyrosine phosphatase, receptor type, B",34 / 986 (3.45%),"601 / 10,202","100 / 1,072 (9.33%)","15 / 1,072 (1.40%)",35,Cancer Gene Census,add to survival plot
DYNC2H1,"dynein, cytoplasmic 2, heavy chain 1",34 / 986 (3.45%),"559 / 10,202","42 / 1,072 (3.92%)","139 / 1,072 (12.97%)",42,,add to survival plot
ERBB2,erb-b2 receptor tyrosine kinase 2,34 / 986 (3.45%),"353 / 10,202","169 / 1,072 (15.76%)","44 / 1,072 (4.10%)",30,Cancer Gene Census,add to survival plot
USP9X,"ubiquitin specific peptidase 9, X-linked",34 / 986 (3.45%),"455 / 10,202","15 / 1,072 (1.40%)","13 / 1,072 (1.21%)",35,,add to survival plot
SSPO,SCO-spondin,34 / 986 (3.45%),"789 / 10,202","49 / 1,072 (4.57%)","66 / 1,072 (6.16%)",37,,add to survival plot
HERC1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,33 / 986 (3.35%),"550 / 10,202","44 / 1,072 (4.10%)","45 / 1,072 (4.20%)",44,,add to survival plot
ATM,ATM serine/threonine kinase,33 / 986 (3.35%),"618 / 10,202","34 / 1,072 (3.17%)","159 / 1,072 (14.83%)",36,Cancer Gene Census,add to survival plot
MYLK,myosin light chain kinase,33 / 986 (3.35%),"497 / 10,202","37 / 1,072 (3.45%)","36 / 1,072 (3.36%)",36,,add to survival plot
DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",33 / 986 (3.35%),"613 / 10,202","62 / 1,072 (5.78%)","56 / 1,072 (5.22%)",36,,add to survival plot
IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),33 / 986 (3.35%),"697 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",38,,add to survival plot
EYS,eyes shut homolog (Drosophila),33 / 986 (3.35%),"671 / 10,202","117 / 1,072 (10.91%)","55 / 1,072 (5.13%)",38,,add to survival plot
TEX15,testis expressed 15,33 / 986 (3.35%),"529 / 10,202","39 / 1,072 (3.64%)","56 / 1,072 (5.22%)",46,,add to survival plot
TSHZ3,teashirt zinc finger homeobox 3,33 / 986 (3.35%),"584 / 10,202","55 / 1,072 (5.13%)","16 / 1,072 (1.49%)",34,,add to survival plot
TPR,"translocated promoter region, nuclear basket protein",33 / 986 (3.35%),"449 / 10,202","117 / 1,072 (10.91%)","26 / 1,072 (2.43%)",36,Cancer Gene Census,add to survival plot
F5,"coagulation factor V (proaccelerin, labile factor)",33 / 986 (3.35%),"482 / 10,202","120 / 1,072 (11.19%)","31 / 1,072 (2.89%)",42,,add to survival plot
COL6A3,"collagen, type VI, alpha 3",33 / 986 (3.35%),"850 / 10,202","32 / 1,072 (2.99%)","90 / 1,072 (8.40%)",35,,add to survival plot
UNC13C,unc-13 homolog C (C. elegans),33 / 986 (3.35%),"719 / 10,202","29 / 1,072 (2.71%)","70 / 1,072 (6.53%)",39,,add to survival plot
PKHD1,polycystic kidney and hepatic disease 1 (autosomal recessive),33 / 986 (3.35%),"861 / 10,202","80 / 1,072 (7.46%)","21 / 1,072 (1.96%)",37,,add to survival plot
ZAN,zonadhesin (gene/pseudogene),33 / 986 (3.35%),"659 / 10,202","42 / 1,072 (3.92%)","37 / 1,072 (3.45%)",34,,add to survival plot
COL12A1,"collagen, type XII, alpha 1",33 / 986 (3.35%),"661 / 10,202","50 / 1,072 (4.66%)","59 / 1,072 (5.50%)",38,,add to survival plot
ADGRG4,adhesion G protein-coupled receptor G4,32 / 986 (3.25%),"734 / 10,202","52 / 1,072 (4.85%)","20 / 1,072 (1.87%)",38,,add to survival plot
F8,"coagulation factor VIII, procoagulant component",32 / 986 (3.25%),"530 / 10,202","69 / 1,072 (6.44%)","30 / 1,072 (2.80%)",34,,add to survival plot
TMEM132D,transmembrane protein 132D,32 / 986 (3.25%),"624 / 10,202","40 / 1,072 (3.73%)","89 / 1,072 (8.30%)",36,,add to survival plot
VPS13C,vacuolar protein sorting 13 homolog C (S. cerevisiae),32 / 986 (3.25%),"507 / 10,202","31 / 1,072 (2.89%)","50 / 1,072 (4.66%)",37,,add to survival plot
QSER1,glutamine and serine rich 1,32 / 986 (3.25%),"303 / 10,202","80 / 1,072 (7.46%)","6 / 1,072 (0.56%)",39,,add to survival plot
MAP1A,microtubule-associated protein 1A,32 / 986 (3.25%),"454 / 10,202","18 / 1,072 (1.68%)","92 / 1,072 (8.58%)",37,,add to survival plot
CENPE,"centromere protein E, 312kDa",32 / 986 (3.25%),"413 / 10,202","44 / 1,072 (4.10%)","33 / 1,072 (3.08%)",37,,add to survival plot
FRAS1,Fraser extracellular matrix complex subunit 1,32 / 986 (3.25%),"695 / 10,202","70 / 1,072 (6.53%)","17 / 1,072 (1.59%)",37,,add to survival plot
CHD7,chromodomain helicase DNA binding protein 7,32 / 986 (3.25%),"589 / 10,202","107 / 1,072 (9.98%)","59 / 1,072 (5.50%)",32,,add to survival plot
WDFY3,WD repeat and FYVE domain containing 3,32 / 986 (3.25%),"635 / 10,202","46 / 1,072 (4.29%)","22 / 1,072 (2.05%)",35,,add to survival plot
PREX2,"phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2",32 / 986 (3.25%),"603 / 10,202","106 / 1,072 (9.89%)","50 / 1,072 (4.66%)",36,,add to survival plot
CEP350,centrosomal protein 350kDa,32 / 986 (3.25%),"448 / 10,202","114 / 1,072 (10.63%)","31 / 1,072 (2.89%)",39,,add to survival plot
AKT1,v-akt murine thymoma viral oncogene homolog 1,32 / 986 (3.25%),"151 / 10,202","73 / 1,072 (6.81%)","54 / 1,072 (5.04%)",8,Cancer Gene Census,add to survival plot
HRNR,hornerin,32 / 986 (3.25%),"736 / 10,202","180 / 1,072 (16.79%)","19 / 1,072 (1.77%)",34,,add to survival plot
REXO1L1P,"REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1, pseudogene",32 / 986 (3.25%),"229 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",30,,add to survival plot
MGAM,maltase-glucoamylase (alpha-glucosidase),31 / 986 (3.14%),"704 / 10,202","58 / 1,072 (5.41%)","45 / 1,072 (4.20%)",34,,add to survival plot
AHCTF1,AT hook containing transcription factor 1,31 / 986 (3.14%),"381 / 10,202","180 / 1,072 (16.79%)","29 / 1,072 (2.71%)",38,,add to survival plot
CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",31 / 986 (3.14%),"528 / 10,202","63 / 1,072 (5.88%)","31 / 1,072 (2.89%)",32,,add to survival plot
UBR5,ubiquitin protein ligase E3 component n-recognin 5,31 / 986 (3.14%),"485 / 10,202","201 / 1,072 (18.75%)","15 / 1,072 (1.40%)",35,Cancer Gene Census,add to survival plot
SHANK2,SH3 and multiple ankyrin repeat domains 2,31 / 986 (3.14%),"496 / 10,202","282 / 1,072 (26.31%)","20 / 1,072 (1.87%)",46,,add to survival plot
PKD1L1,polycystic kidney disease 1 like 1,31 / 986 (3.14%),"569 / 10,202","37 / 1,072 (3.45%)","20 / 1,072 (1.87%)",36,,add to survival plot
MYO18B,myosin XVIIIB,31 / 986 (3.14%),"675 / 10,202","47 / 1,072 (4.38%)","25 / 1,072 (2.33%)",32,,add to survival plot
DNAH7,"dynein, axonemal, heavy chain 7",31 / 986 (3.14%),"898 / 10,202","56 / 1,072 (5.22%)","23 / 1,072 (2.15%)",36,,add to survival plot
AFF2,"AF4/FMR2 family, member 2",31 / 986 (3.14%),"553 / 10,202","60 / 1,072 (5.60%)","26 / 1,072 (2.43%)",34,,add to survival plot
DNAH2,"dynein, axonemal, heavy chain 2",31 / 986 (3.14%),"726 / 10,202","17 / 1,072 (1.59%)","43 / 1,072 (4.01%)",39,,add to survival plot
CHD4,chromodomain helicase DNA binding protein 4,31 / 986 (3.14%),"490 / 10,202","73 / 1,072 (6.81%)","45 / 1,072 (4.20%)",36,Cancer Gene Census,add to survival plot
SMG1,SMG1 phosphatidylinositol 3-kinase-related kinase,30 / 986 (3.04%),"452 / 10,202","52 / 1,072 (4.85%)","16 / 1,072 (1.49%)",36,,add to survival plot
CMYA5,cardiomyopathy associated 5,30 / 986 (3.04%),"649 / 10,202","8 / 1,072 (0.75%)","65 / 1,072 (6.06%)",45,,add to survival plot
DNAH1,"dynein, axonemal, heavy chain 1",30 / 986 (3.04%),"573 / 10,202","13 / 1,072 (1.21%)","143 / 1,072 (13.34%)",34,,add to survival plot
FLG2,filaggrin family member 2,30 / 986 (3.04%),"672 / 10,202","178 / 1,072 (16.60%)","19 / 1,072 (1.77%)",36,,add to survival plot
ASTN1,astrotactin 1,30 / 986 (3.04%),"602 / 10,202","117 / 1,072 (10.91%)","33 / 1,072 (3.08%)",32,,add to survival plot
COL14A1,"collagen, type XIV, alpha 1",30 / 986 (3.04%),"511 / 10,202","202 / 1,072 (18.84%)","19 / 1,072 (1.77%)",40,,add to survival plot
FRMPD4,FERM and PDZ domain containing 4,30 / 986 (3.04%),"433 / 10,202","41 / 1,072 (3.82%)","23 / 1,072 (2.15%)",32,,add to survival plot
LCT,lactase,30 / 986 (3.04%),"565 / 10,202","19 / 1,072 (1.77%)","47 / 1,072 (4.38%)",32,,add to survival plot
ARID1B,AT rich interactive domain 1B (SWI1-like),30 / 986 (3.04%),"489 / 10,202","54 / 1,072 (5.04%)","99 / 1,072 (9.24%)",30,Cancer Gene Census,add to survival plot
ZNF292,zinc finger protein 292,30 / 986 (3.04%),"454 / 10,202","27 / 1,072 (2.52%)","87 / 1,072 (8.12%)",37,,add to survival plot
SCN2A,"sodium channel, voltage gated, type II alpha subunit",30 / 986 (3.04%),"591 / 10,202","34 / 1,072 (3.17%)","21 / 1,072 (1.96%)",36,,add to survival plot
ITPR3,"inositol 1,4,5-trisphosphate receptor, type 3",30 / 986 (3.04%),"467 / 10,202","71 / 1,072 (6.62%)","29 / 1,072 (2.71%)",34,,add to survival plot
FLNC,"filamin C, gamma",30 / 986 (3.04%),"657 / 10,202","53 / 1,072 (4.94%)","35 / 1,072 (3.26%)",30,,add to survival plot
PXDNL,peroxidasin-like,30 / 986 (3.04%),"657 / 10,202","91 / 1,072 (8.49%)","77 / 1,072 (7.18%)",34,,add to survival plot
MYO10,myosin X,30 / 986 (3.04%),"404 / 10,202","73 / 1,072 (6.81%)","13 / 1,072 (1.21%)",32,,add to survival plot
SDK1,sidekick cell adhesion molecule 1,30 / 986 (3.04%),"683 / 10,202","58 / 1,072 (5.41%)","55 / 1,072 (5.13%)",34,,add to survival plot
FREM1,FRAS1 related extracellular matrix 1,30 / 986 (3.04%),"513 / 10,202","48 / 1,072 (4.48%)","36 / 1,072 (3.36%)",32,,add to survival plot
PDZD2,PDZ domain containing 2,30 / 986 (3.04%),"615 / 10,202","58 / 1,072 (5.41%)","19 / 1,072 (1.77%)",34,,add to survival plot
TCHH,trichohyalin,30 / 986 (3.04%),"462 / 10,202","178 / 1,072 (16.60%)","19 / 1,072 (1.77%)",35,,add to survival plot
MTOR,mechanistic target of rapamycin (serine/threonine kinase),29 / 986 (2.94%),"444 / 10,202","24 / 1,072 (2.24%)","170 / 1,072 (15.86%)",30,Cancer Gene Census,add to survival plot
BRWD1,bromodomain and WD repeat domain containing 1,29 / 986 (2.94%),"382 / 10,202","76 / 1,072 (7.09%)","15 / 1,072 (1.40%)",31,,add to survival plot
ZNF536,zinc finger protein 536,29 / 986 (2.94%),"837 / 10,202","80 / 1,072 (7.46%)","17 / 1,072 (1.59%)",31,,add to survival plot
CNTNAP5,contactin associated protein-like 5,29 / 986 (2.94%),"711 / 10,202","21 / 1,072 (1.96%)","40 / 1,072 (3.73%)",32,,add to survival plot
BRCA1,"breast cancer 1, early onset",29 / 986 (2.94%),"332 / 10,202","41 / 1,072 (3.82%)","90 / 1,072 (8.40%)",29,Cancer Gene Census,add to survival plot
BRCA2,"breast cancer 2, early onset",29 / 986 (2.94%),"517 / 10,202","73 / 1,072 (6.81%)","87 / 1,072 (8.12%)",33,Cancer Gene Census,add to survival plot
PCNT,pericentrin,29 / 986 (2.94%),"510 / 10,202","79 / 1,072 (7.37%)","21 / 1,072 (1.96%)",34,,add to survival plot
VPS13D,vacuolar protein sorting 13 homolog D (S. cerevisiae),29 / 986 (2.94%),"611 / 10,202","22 / 1,072 (2.05%)","174 / 1,072 (16.23%)",36,,add to survival plot
TNRC6B,trinucleotide repeat containing 6B,29 / 986 (2.94%),"467 / 10,202","33 / 1,072 (3.08%)","26 / 1,072 (2.43%)",28,,add to survival plot
SCN10A,"sodium channel, voltage gated, type X alpha subunit",29 / 986 (2.94%),"610 / 10,202","33 / 1,072 (3.08%)","81 / 1,072 (7.56%)",35,,add to survival plot
FLNB,"filamin B, beta",29 / 986 (2.94%),"472 / 10,202","15 / 1,072 (1.40%)","139 / 1,072 (12.97%)",30,,add to survival plot
WDFY4,WDFY family member 4,29 / 986 (2.94%),"318 / 10,202","45 / 1,072 (4.20%)","35 / 1,072 (3.26%)",34,,add to survival plot
CR1,complement component (3b/4b) receptor 1 (Knops blood group),29 / 986 (2.94%),"469 / 10,202","153 / 1,072 (14.27%)","15 / 1,072 (1.40%)",33,,add to survival plot
RIMS2,regulating synaptic membrane exocytosis 2,29 / 986 (2.94%),"740 / 10,202","206 / 1,072 (19.22%)","17 / 1,072 (1.59%)",32,,add to survival plot
OPRM1,"opioid receptor, mu 1",29 / 986 (2.94%),"298 / 10,202","62 / 1,072 (5.78%)","80 / 1,072 (7.46%)",19,,add to survival plot
MYO15A,myosin XVA,29 / 986 (2.94%),"593 / 10,202","47 / 1,072 (4.38%)","29 / 1,072 (2.71%)",28,,add to survival plot
PLXNA4,plexin A4,29 / 986 (2.94%),"710 / 10,202","63 / 1,072 (5.88%)","34 / 1,072 (3.17%)",33,,add to survival plot
CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit",29 / 986 (2.94%),"390 / 10,202","32 / 1,072 (2.99%)","10 / 1,072 (0.93%)",30,,add to survival plot
NOTCH2,notch 2,29 / 986 (2.94%),"400 / 10,202","198 / 1,072 (18.47%)","52 / 1,072 (4.85%)",31,Cancer Gene Census,add to survival plot
TRRAP,transformation/transcription domain-associated protein,25 / 986 (2.54%),"683 / 10,202","42 / 1,072 (3.92%)","38 / 1,072 (3.54%)",31,Cancer Gene Census,add to survival plot
CREBBP,CREB binding protein,25 / 986 (2.54%),"578 / 10,202","67 / 1,072 (6.25%)","25 / 1,072 (2.33%)",27,Cancer Gene Census,add to survival plot
MYO5B,myosin VB,25 / 986 (2.54%),"357 / 10,202","24 / 1,072 (2.24%)","43 / 1,072 (4.01%)",25,,add to survival plot
DMXL2,Dmx-like 2,25 / 986 (2.54%),"476 / 10,202","41 / 1,072 (3.82%)","71 / 1,072 (6.62%)",32,,add to survival plot
MYO7A,myosin VIIA,25 / 986 (2.54%),"400 / 10,202","178 / 1,072 (16.60%)","28 / 1,072 (2.61%)",26,,add to survival plot
BAZ2B,"bromodomain adjacent to zinc finger domain, 2B",25 / 986 (2.54%),"421 / 10,202","30 / 1,072 (2.80%)","26 / 1,072 (2.43%)",31,,add to survival plot
ZNF462,zinc finger protein 462,25 / 986 (2.54%),"450 / 10,202","28 / 1,072 (2.61%)","40 / 1,072 (3.73%)",28,,add to survival plot
LOXHD1,lipoxygenase homology domains 1,25 / 986 (2.54%),"228 / 10,202","25 / 1,072 (2.33%)","26 / 1,072 (2.43%)",25,,add to survival plot
MYH8,"myosin, heavy chain 8, skeletal muscle, perinatal",25 / 986 (2.54%),"622 / 10,202","11 / 1,072 (1.03%)","31 / 1,072 (2.89%)",26,,add to survival plot
SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",25 / 986 (2.54%),"380 / 10,202","36 / 1,072 (3.36%)","57 / 1,072 (5.32%)",25,,add to survival plot
ARHGEF11,Rho guanine nucleotide exchange factor (GEF) 11,25 / 986 (2.54%),"347 / 10,202","149 / 1,072 (13.90%)","27 / 1,072 (2.52%)",28,,add to survival plot
PCDH19,protocadherin 19,25 / 986 (2.54%),"418 / 10,202","13 / 1,072 (1.21%)","25 / 1,072 (2.33%)",27,,add to survival plot
MYH7,"myosin, heavy chain 7, cardiac muscle, beta",25 / 986 (2.54%),"591 / 10,202","88 / 1,072 (8.21%)","25 / 1,072 (2.33%)",27,,add to survival plot
ATP2B1,"ATPase, Ca++ transporting, plasma membrane 1",25 / 986 (2.54%),"273 / 10,202","55 / 1,072 (5.13%)","50 / 1,072 (4.66%)",30,,add to survival plot
SETX,senataxin,25 / 986 (2.54%),"421 / 10,202","48 / 1,072 (4.48%)","36 / 1,072 (3.36%)",33,,add to survival plot
MRC1,"mannose receptor, C type 1",24 / 986 (2.43%),"493 / 10,202","69 / 1,072 (6.44%)","15 / 1,072 (1.40%)",25,,add to survival plot
GRIA3,"glutamate receptor, ionotropic, AMPA 3",24 / 986 (2.43%),"355 / 10,202","34 / 1,072 (3.17%)","22 / 1,072 (2.05%)",25,,add to survival plot
BSN,bassoon presynaptic cytomatrix protein,24 / 986 (2.43%),"578 / 10,202","14 / 1,072 (1.31%)","147 / 1,072 (13.71%)",29,,add to survival plot
BRWD3,bromodomain and WD repeat domain containing 3,24 / 986 (2.43%),"427 / 10,202","16 / 1,072 (1.49%)","20 / 1,072 (1.87%)",26,,add to survival plot
RIMBP2,RIMS binding protein 2,24 / 986 (2.43%),"491 / 10,202","40 / 1,072 (3.73%)","88 / 1,072 (8.21%)",25,,add to survival plot
NBAS,neuroblastoma amplified sequence,24 / 986 (2.43%),"434 / 10,202","36 / 1,072 (3.36%)","45 / 1,072 (4.20%)",27,,add to survival plot
CDH12,"cadherin 12, type 2 (N-cadherin 2)",24 / 986 (2.43%),"545 / 10,202","76 / 1,072 (7.09%)","17 / 1,072 (1.59%)",23,,add to survival plot
SCN7A,"sodium channel, voltage gated, type VII alpha subunit",24 / 986 (2.43%),"453 / 10,202","34 / 1,072 (3.17%)","23 / 1,072 (2.15%)",26,,add to survival plot
TACC2,"transforming, acidic coiled-coil containing protein 2",24 / 986 (2.43%),"536 / 10,202","54 / 1,072 (5.04%)","70 / 1,072 (6.53%)",32,,add to survival plot
CPAMD8,"C3 and PZP-like, alpha-2-macroglobulin domain containing 8",24 / 986 (2.43%),"489 / 10,202","56 / 1,072 (5.22%)","18 / 1,072 (1.68%)",26,,add to survival plot
DMXL1,Dmx-like 1,24 / 986 (2.43%),"433 / 10,202","25 / 1,072 (2.33%)","48 / 1,072 (4.48%)",29,,add to survival plot
KIF1B,kinesin family member 1B,24 / 986 (2.43%),"431 / 10,202","23 / 1,072 (2.15%)","169 / 1,072 (15.76%)",22,,add to survival plot
SCN5A,"sodium channel, voltage gated, type V alpha subunit",24 / 986 (2.43%),"599 / 10,202","34 / 1,072 (3.17%)","80 / 1,072 (7.46%)",26,,add to survival plot
MYH10,"myosin, heavy chain 10, non-muscle",24 / 986 (2.43%),"346 / 10,202","22 / 1,072 (2.05%)","38 / 1,072 (3.54%)",25,,add to survival plot
MYH11,"myosin, heavy chain 11, smooth muscle",24 / 986 (2.43%),"515 / 10,202","61 / 1,072 (5.69%)","9 / 1,072 (0.84%)",29,Cancer Gene Census,add to survival plot
ZFHX3,zinc finger homeobox 3,24 / 986 (2.43%),"719 / 10,202","31 / 1,072 (2.89%)","46 / 1,072 (4.29%)",30,Cancer Gene Census,add to survival plot
MKI67,marker of proliferation Ki-67,24 / 986 (2.43%),"593 / 10,202","48 / 1,072 (4.48%)","78 / 1,072 (7.28%)",29,,add to survival plot
HDAC6,histone deacetylase 6,24 / 986 (2.43%),"274 / 10,202","33 / 1,072 (3.08%)","9 / 1,072 (0.84%)",24,,add to survival plot
ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",24 / 986 (2.43%),"596 / 10,202","36 / 1,072 (3.36%)","48 / 1,072 (4.48%)",25,,add to survival plot
SNRNP200,small nuclear ribonucleoprotein 200kDa (U5),24 / 986 (2.43%),"390 / 10,202","53 / 1,072 (4.94%)","21 / 1,072 (1.96%)",25,,add to survival plot
KMT2E,lysine (K)-specific methyltransferase 2E,24 / 986 (2.43%),"363 / 10,202","35 / 1,072 (3.26%)","47 / 1,072 (4.38%)",24,,add to survival plot
YLPM1,YLP motif containing 1,24 / 986 (2.43%),"368 / 10,202","17 / 1,072 (1.59%)","82 / 1,072 (7.65%)",29,,add to survival plot
PHKA2,"phosphorylase kinase, alpha 2 (liver)",24 / 986 (2.43%),"305 / 10,202","42 / 1,072 (3.92%)","13 / 1,072 (1.21%)",26,,add to survival plot
MAGEA12,melanoma antigen family A12,24 / 986 (2.43%),"281 / 10,202","62 / 1,072 (5.78%)","24 / 1,072 (2.24%)",24,,add to survival plot
PIWIL1,piwi-like RNA-mediated gene silencing 1,24 / 986 (2.43%),"343 / 10,202","37 / 1,072 (3.45%)","87 / 1,072 (8.12%)",23,,add to survival plot
GOLGA6L10,golgin A6 family-like 10,24 / 986 (2.43%),"211 / 10,202","77 / 1,072 (7.18%)","16 / 1,072 (1.49%)",14,,add to survival plot
ADAMTSL1,ADAMTS-like 1,24 / 986 (2.43%),"448 / 10,202","46 / 1,072 (4.29%)","26 / 1,072 (2.43%)",26,,add to survival plot
ARHGAP35,Rho GTPase activating protein 35,24 / 986 (2.43%),"406 / 10,202","34 / 1,072 (3.17%)","73 / 1,072 (6.81%)",27,,add to survival plot
TENM3,teneurin transmembrane protein 3,24 / 986 (2.43%),"708 / 10,202","51 / 1,072 (4.76%)","74 / 1,072 (6.90%)",26,,add to survival plot
NAV2,neuron navigator 2,24 / 986 (2.43%),"517 / 10,202","68 / 1,072 (6.34%)","32 / 1,072 (2.99%)",25,,add to survival plot
KAT6B,K(lysine) acetyltransferase 6B,24 / 986 (2.43%),"326 / 10,202","81 / 1,072 (7.56%)","27 / 1,072 (2.52%)",28,Cancer Gene Census,add to survival plot
DNAJC13,"DnaJ (Hsp40) homolog, subfamily C, member 13",24 / 986 (2.43%),"339 / 10,202","43 / 1,072 (4.01%)","34 / 1,072 (3.17%)",27,,add to survival plot
ANKRD11,ankyrin repeat domain 11,24 / 986 (2.43%),"491 / 10,202","42 / 1,072 (3.92%)","66 / 1,072 (6.16%)",30,,add to survival plot
POTEM,"POTE ankyrin domain family, member M",24 / 986 (2.43%),"236 / 10,202","87 / 1,072 (8.12%)","28 / 1,072 (2.61%)",16,,add to survival plot
CIT,citron rho-interacting serine/threonine kinase,24 / 986 (2.43%),"444 / 10,202","40 / 1,072 (3.73%)","80 / 1,072 (7.46%)",25,,add to survival plot
C2orf16,chromosome 2 open reading frame 16,24 / 986 (2.43%),"387 / 10,202","40 / 1,072 (3.73%)","27 / 1,072 (2.52%)",30,,add to survival plot
REV3L,"REV3-like, polymerase (DNA directed), zeta, catalytic subunit",24 / 986 (2.43%),"434 / 10,202","62 / 1,072 (5.78%)","66 / 1,072 (6.16%)",29,,add to survival plot
ZNF440,zinc finger protein 440,24 / 986 (2.43%),"272 / 10,202","45 / 1,072 (4.20%)","43 / 1,072 (4.01%)",20,,add to survival plot
SI,sucrase-isomaltase (alpha-glucosidase),24 / 986 (2.43%),"749 / 10,202","118 / 1,072 (11.01%)","16 / 1,072 (1.49%)",25,,add to survival plot
HEATR1,HEAT repeat containing 1,24 / 986 (2.43%),"359 / 10,202","168 / 1,072 (15.67%)","31 / 1,072 (2.89%)",28,,add to survival plot
NUP188,nucleoporin 188kDa,24 / 986 (2.43%),"279 / 10,202","50 / 1,072 (4.66%)","34 / 1,072 (3.17%)",28,,add to survival plot
KIF13A,kinesin family member 13A,24 / 986 (2.43%),"327 / 10,202","105 / 1,072 (9.79%)","27 / 1,072 (2.52%)",27,,add to survival plot
TRPM3,"transient receptor potential cation channel, subfamily M, member 3",24 / 986 (2.43%),"488 / 10,202","39 / 1,072 (3.64%)","38 / 1,072 (3.54%)",26,,add to survival plot
KALRN,"kalirin, RhoGEF kinase",24 / 986 (2.43%),"617 / 10,202","48 / 1,072 (4.48%)","38 / 1,072 (3.54%)",31,,add to survival plot
MED13,mediator complex subunit 13,24 / 986 (2.43%),"433 / 10,202","232 / 1,072 (21.64%)","11 / 1,072 (1.03%)",30,,add to survival plot
SRRM2,serine/arginine repetitive matrix 2,24 / 986 (2.43%),"500 / 10,202","80 / 1,072 (7.46%)","18 / 1,072 (1.68%)",32,,add to survival plot
EHMT1,euchromatic histone-lysine N-methyltransferase 1,24 / 986 (2.43%),"322 / 10,202","60 / 1,072 (5.60%)","43 / 1,072 (4.01%)",25,,add to survival plot
NBEAL1,neurobeachin-like 1,24 / 986 (2.43%),"327 / 10,202","53 / 1,072 (4.94%)","34 / 1,072 (3.17%)",29,,add to survival plot
IGF2R,insulin-like growth factor 2 receptor,23 / 986 (2.33%),"463 / 10,202","56 / 1,072 (5.22%)","102 / 1,072 (9.51%)",25,,add to survival plot
FASN,fatty acid synthase,23 / 986 (2.33%),"353 / 10,202","195 / 1,072 (18.19%)","42 / 1,072 (3.92%)",26,,add to survival plot
ICE1,interactor of little elongation complex ELL subunit 1,23 / 986 (2.33%),"417 / 10,202","80 / 1,072 (7.46%)","16 / 1,072 (1.49%)",27,,add to survival plot
RAB3GAP2,RAB3 GTPase activating protein subunit 2 (non-catalytic),23 / 986 (2.33%),"367 / 10,202","140 / 1,072 (13.06%)","32 / 1,072 (2.99%)",25,,add to survival plot
SCN9A,"sodium channel, voltage gated, type IX alpha subunit",23 / 986 (2.33%),"532 / 10,202","33 / 1,072 (3.08%)","23 / 1,072 (2.15%)",29,,add to survival plot
IGSF10,"immunoglobulin superfamily, member 10",23 / 986 (2.33%),"527 / 10,202","91 / 1,072 (8.49%)","12 / 1,072 (1.12%)",25,,add to survival plot
PCDHB6,protocadherin beta 6,23 / 986 (2.33%),"626 / 10,202","46 / 1,072 (4.29%)","21 / 1,072 (1.96%)",23,,add to survival plot
NUP210L,nucleoporin 210kDa-like,23 / 986 (2.33%),"403 / 10,202","168 / 1,072 (15.67%)","23 / 1,072 (2.15%)",24,,add to survival plot
CTCF,CCCTC-binding factor (zinc finger protein),23 / 986 (2.33%),"336 / 10,202","19 / 1,072 (1.77%)","47 / 1,072 (4.38%)",23,Cancer Gene Census,add to survival plot
SEMA3D,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D",23 / 986 (2.33%),"321 / 10,202","34 / 1,072 (3.17%)","32 / 1,072 (2.99%)",24,,add to survival plot
MIA3,"melanoma inhibitory activity family, member 3",23 / 986 (2.33%),"327 / 10,202","142 / 1,072 (13.25%)","26 / 1,072 (2.43%)",26,,add to survival plot
AC215219.2,AC215219.2,23 / 986 (2.33%),"215 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",16,,add to survival plot
TJP1,tight junction protein 1,23 / 986 (2.33%),"319 / 10,202","34 / 1,072 (3.17%)","100 / 1,072 (9.33%)",26,,add to survival plot
DOCK10,dedicator of cytokinesis 10,23 / 986 (2.33%),"432 / 10,202","31 / 1,072 (2.89%)","65 / 1,072 (6.06%)",26,,add to survival plot
CEP162,centrosomal protein 162kDa,23 / 986 (2.33%),"253 / 10,202","32 / 1,072 (2.99%)","75 / 1,072 (7.00%)",25,,add to survival plot
AKAP6,A kinase (PRKA) anchor protein 6,23 / 986 (2.33%),"548 / 10,202","96 / 1,072 (8.96%)","19 / 1,072 (1.77%)",26,,add to survival plot
WNK3,WNK lysine deficient protein kinase 3,23 / 986 (2.33%),"371 / 10,202","45 / 1,072 (4.20%)","9 / 1,072 (0.84%)",31,,add to survival plot
COL7A1,"collagen, type VII, alpha 1",23 / 986 (2.33%),"562 / 10,202","15 / 1,072 (1.40%)","138 / 1,072 (12.87%)",24,,add to survival plot
CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",23 / 986 (2.33%),"469 / 10,202","39 / 1,072 (3.64%)","39 / 1,072 (3.64%)",26,,add to survival plot
MYOM2,myomesin 2,23 / 986 (2.33%),"469 / 10,202","31 / 1,072 (2.89%)","97 / 1,072 (9.05%)",25,,add to survival plot
NCKAP5,NCK-associated protein 5,23 / 986 (2.33%),"552 / 10,202","24 / 1,072 (2.24%)","41 / 1,072 (3.82%)",24,,add to survival plot
COL5A1,"collagen, type V, alpha 1",23 / 986 (2.33%),"606 / 10,202","49 / 1,072 (4.57%)","44 / 1,072 (4.10%)",25,,add to survival plot
CSPP1,centrosome and spindle pole associated protein 1,23 / 986 (2.33%),"268 / 10,202","103 / 1,072 (9.61%)","44 / 1,072 (4.10%)",29,,add to survival plot
PLCH1,"phospholipase C, eta 1",23 / 986 (2.33%),"476 / 10,202","103 / 1,072 (9.61%)","13 / 1,072 (1.21%)",27,,add to survival plot
CASP8,"caspase 8, apoptosis-related cysteine peptidase",23 / 986 (2.33%),"289 / 10,202","48 / 1,072 (4.48%)","31 / 1,072 (2.89%)",24,Cancer Gene Census,add to survival plot
ZFP36L1,ZFP36 ring finger protein-like 1,23 / 986 (2.33%),"294 / 10,202","20 / 1,072 (1.87%)","83 / 1,072 (7.74%)",21,,add to survival plot
ANKRD36,ankyrin repeat domain 36,23 / 986 (2.33%),"255 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",30,,add to survival plot
TNC,tenascin C,23 / 986 (2.33%),"470 / 10,202","44 / 1,072 (4.10%)","30 / 1,072 (2.80%)",29,,add to survival plot
ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",23 / 986 (2.33%),"388 / 10,202","65 / 1,072 (6.06%)","25 / 1,072 (2.33%)",24,Cancer Gene Census,add to survival plot
MYH13,"myosin, heavy chain 13, skeletal muscle",23 / 986 (2.33%),"570 / 10,202","12 / 1,072 (1.12%)","33 / 1,072 (3.08%)",23,,add to survival plot
KIAA2018,KIAA2018,23 / 986 (2.33%),"400 / 10,202","55 / 1,072 (5.13%)","26 / 1,072 (2.43%)",24,,add to survival plot
FRY,furry homolog (Drosophila),23 / 986 (2.33%),"557 / 10,202","75 / 1,072 (7.00%)","85 / 1,072 (7.93%)",24,,add to survival plot
ANKRD30A,ankyrin repeat domain 30A,23 / 986 (2.33%),"602 / 10,202","53 / 1,072 (4.94%)","27 / 1,072 (2.52%)",24,,add to survival plot
ERICH3,glutamate-rich 3,23 / 986 (2.33%),"694 / 10,202","41 / 1,072 (3.82%)","60 / 1,072 (5.60%)",27,,add to survival plot
CNTN4,contactin 4,23 / 986 (2.33%),"451 / 10,202","96 / 1,072 (8.96%)","44 / 1,072 (4.10%)",26,,add to survival plot
MICAL2,"microtubule associated monooxygenase, calponin and LIM domain containing 2",23 / 986 (2.33%),"293 / 10,202","41 / 1,072 (3.82%)","58 / 1,072 (5.41%)",25,,add to survival plot
PLCE1,"phospholipase C, epsilon 1",23 / 986 (2.33%),"496 / 10,202","27 / 1,072 (2.52%)","72 / 1,072 (6.72%)",25,,add to survival plot
ST18,"suppression of tumorigenicity 18, zinc finger",23 / 986 (2.33%),"473 / 10,202","91 / 1,072 (8.49%)","64 / 1,072 (5.97%)",23,,add to survival plot
DIDO1,death inducer-obliterator 1,23 / 986 (2.33%),"561 / 10,202","136 / 1,072 (12.69%)","30 / 1,072 (2.80%)",31,,add to survival plot
CENPF,"centromere protein F, 350/400kDa",23 / 986 (2.33%),"523 / 10,202","135 / 1,072 (12.59%)","31 / 1,072 (2.89%)",28,,add to survival plot
OGT,O-linked N-acetylglucosamine (GlcNAc) transferase,23 / 986 (2.33%),"290 / 10,202","22 / 1,072 (2.05%)","23 / 1,072 (2.15%)",27,,add to survival plot
NRXN3,neurexin 3,23 / 986 (2.33%),"629 / 10,202","25 / 1,072 (2.33%)","90 / 1,072 (8.40%)",26,,add to survival plot
LAMA3,"laminin, alpha 3",23 / 986 (2.33%),"539 / 10,202","36 / 1,072 (3.36%)","18 / 1,072 (1.68%)",23,,add to survival plot
RBBP6,retinoblastoma binding protein 6,23 / 986 (2.33%),"349 / 10,202","46 / 1,072 (4.29%)","12 / 1,072 (1.12%)",24,,add to survival plot
ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",23 / 986 (2.33%),"474 / 10,202","45 / 1,072 (4.20%)","34 / 1,072 (3.17%)",24,,add to survival plot
BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",23 / 986 (2.33%),"312 / 10,202","37 / 1,072 (3.45%)","78 / 1,072 (7.28%)",22,,add to survival plot
EP300,E1A binding protein p300,23 / 986 (2.33%),"507 / 10,202","35 / 1,072 (3.26%)","32 / 1,072 (2.99%)",23,Cancer Gene Census,add to survival plot
SPTB,"spectrin, beta, erythrocytic",23 / 986 (2.33%),"477 / 10,202","33 / 1,072 (3.08%)","65 / 1,072 (6.06%)",23,,add to survival plot
EPHB1,EPH receptor B1,23 / 986 (2.33%),"466 / 10,202","60 / 1,072 (5.60%)","27 / 1,072 (2.52%)",24,,add to survival plot
ZFPM2,"zinc finger protein, FOG family member 2",23 / 986 (2.33%),"487 / 10,202","207 / 1,072 (19.31%)","15 / 1,072 (1.40%)",24,,add to survival plot
CFAP44,cilia and flagella associated protein 44,23 / 986 (2.33%),"253 / 10,202","52 / 1,072 (4.85%)","27 / 1,072 (2.52%)",27,,add to survival plot
CADPS,Ca++-dependent secretion activator,23 / 986 (2.33%),"403 / 10,202","15 / 1,072 (1.40%)","134 / 1,072 (12.50%)",24,,add to survival plot
TET2,tet methylcytosine dioxygenase 2,22 / 986 (2.23%),"425 / 10,202","40 / 1,072 (3.73%)","39 / 1,072 (3.64%)",26,Cancer Gene Census,add to survival plot
SIPA1L1,signal-induced proliferation-associated 1 like 1,22 / 986 (2.23%),"419 / 10,202","16 / 1,072 (1.49%)","80 / 1,072 (7.46%)",22,,add to survival plot
SPEG,SPEG complex locus,22 / 986 (2.23%),"600 / 10,202","35 / 1,072 (3.26%)","52 / 1,072 (4.85%)",22,,add to survival plot
SVIL,supervillin,22 / 986 (2.23%),"486 / 10,202","28 / 1,072 (2.61%)","30 / 1,072 (2.80%)",23,,add to survival plot
OR2L13,"olfactory receptor, family 2, subfamily L, member 13",22 / 986 (2.23%),"426 / 10,202","180 / 1,072 (16.79%)","34 / 1,072 (3.17%)",23,,add to survival plot
SLIT2,slit homolog 2 (Drosophila),22 / 986 (2.23%),"542 / 10,202","18 / 1,072 (1.68%)","32 / 1,072 (2.99%)",24,,add to survival plot
MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",22 / 986 (2.23%),"550 / 10,202","87 / 1,072 (8.12%)","25 / 1,072 (2.33%)",23,,add to survival plot
SIPA1L2,signal-induced proliferation-associated 1 like 2,22 / 986 (2.23%),"442 / 10,202","158 / 1,072 (14.74%)","31 / 1,072 (2.89%)",26,,add to survival plot
RAPGEF6,Rap guanine nucleotide exchange factor (GEF) 6,22 / 986 (2.23%),"277 / 10,202","27 / 1,072 (2.52%)","38 / 1,072 (3.54%)",22,,add to survival plot
PIEZO2,piezo-type mechanosensitive ion channel component 2,22 / 986 (2.23%),"328 / 10,202","35 / 1,072 (3.26%)","20 / 1,072 (1.87%)",23,,add to survival plot
LAMB1,"laminin, beta 1",22 / 986 (2.23%),"398 / 10,202","35 / 1,072 (3.26%)","40 / 1,072 (3.73%)",23,,add to survival plot
KDM5B,lysine (K)-specific demethylase 5B,22 / 986 (2.23%),"318 / 10,202","152 / 1,072 (14.18%)","9 / 1,072 (0.84%)",27,,add to survival plot
ROS1,"ROS proto-oncogene 1 , receptor tyrosine kinase",22 / 986 (2.23%),"551 / 10,202","58 / 1,072 (5.41%)","53 / 1,072 (4.94%)",25,Cancer Gene Census,add to survival plot
TNXB,tenascin XB,22 / 986 (2.23%),"669 / 10,202","77 / 1,072 (7.18%)","31 / 1,072 (2.89%)",26,,add to survival plot
FAM47C,"family with sequence similarity 47, member C",22 / 986 (2.23%),"547 / 10,202","17 / 1,072 (1.59%)","19 / 1,072 (1.77%)",23,,add to survival plot
MYH14,"myosin, heavy chain 14, non-muscle",22 / 986 (2.23%),"370 / 10,202","61 / 1,072 (5.69%)","44 / 1,072 (4.10%)",22,,add to survival plot
ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",22 / 986 (2.23%),"450 / 10,202","112 / 1,072 (10.45%)","37 / 1,072 (3.45%)",25,,add to survival plot
TRPC5,"transient receptor potential cation channel, subfamily C, member 5",22 / 986 (2.23%),"341 / 10,202","26 / 1,072 (2.43%)","26 / 1,072 (2.43%)",23,,add to survival plot
MED12L,mediator complex subunit 12-like,22 / 986 (2.23%),"510 / 10,202","96 / 1,072 (8.96%)","15 / 1,072 (1.40%)",25,,add to survival plot
XRN1,5'-3' exoribonuclease 1,22 / 986 (2.23%),"341 / 10,202","75 / 1,072 (7.00%)","23 / 1,072 (2.15%)",23,,add to survival plot
TNRC6A,trinucleotide repeat containing 6A,22 / 986 (2.23%),"422 / 10,202","49 / 1,072 (4.57%)","11 / 1,072 (1.03%)",26,,add to survival plot
ANKRD17,ankyrin repeat domain 17,22 / 986 (2.23%),"380 / 10,202","97 / 1,072 (9.05%)","11 / 1,072 (1.03%)",26,,add to survival plot
DSP,desmoplakin,22 / 986 (2.23%),"565 / 10,202","89 / 1,072 (8.30%)","52 / 1,072 (4.85%)",28,,add to survival plot
ZNF208,zinc finger protein 208,22 / 986 (2.23%),"534 / 10,202","52 / 1,072 (4.85%)","24 / 1,072 (2.24%)",25,,add to survival plot
SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",22 / 986 (2.23%),"493 / 10,202","57 / 1,072 (5.32%)","41 / 1,072 (3.82%)",22,Cancer Gene Census,add to survival plot
TRPM6,"transient receptor potential cation channel, subfamily M, member 6",22 / 986 (2.23%),"479 / 10,202","26 / 1,072 (2.43%)","37 / 1,072 (3.45%)",25,,add to survival plot
CEP170,centrosomal protein 170kDa,22 / 986 (2.23%),"339 / 10,202","169 / 1,072 (15.76%)","30 / 1,072 (2.80%)",22,,add to survival plot
CHD9,chromodomain helicase DNA binding protein 9,22 / 986 (2.23%),"411 / 10,202","51 / 1,072 (4.76%)","37 / 1,072 (3.45%)",26,,add to survival plot
RP1L1,retinitis pigmentosa 1-like 1,22 / 986 (2.23%),"646 / 10,202","21 / 1,072 (1.96%)","74 / 1,072 (6.90%)",20,,add to survival plot
MRC2,"mannose receptor, C type 2",22 / 986 (2.23%),"316 / 10,202","233 / 1,072 (21.74%)","12 / 1,072 (1.12%)",23,,add to survival plot
DYSF,dysferlin,22 / 986 (2.23%),"614 / 10,202","42 / 1,072 (3.92%)","10 / 1,072 (0.93%)",26,,add to survival plot
ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",22 / 986 (2.23%),"323 / 10,202","18 / 1,072 (1.68%)","18 / 1,072 (1.68%)",24,,add to survival plot
MYO3A,myosin IIIA,22 / 986 (2.23%),"547 / 10,202","29 / 1,072 (2.71%)","24 / 1,072 (2.24%)",30,,add to survival plot
ARID4B,AT rich interactive domain 4B (RBP1-like),22 / 986 (2.23%),"329 / 10,202","174 / 1,072 (16.23%)","29 / 1,072 (2.71%)",23,,add to survival plot
TRAPPC9,trafficking protein particle complex 9,22 / 986 (2.23%),"279 / 10,202","187 / 1,072 (17.44%)","57 / 1,072 (5.32%)",23,,add to survival plot
ACACA,acetyl-CoA carboxylase alpha,22 / 986 (2.23%),"427 / 10,202","81 / 1,072 (7.56%)","75 / 1,072 (7.00%)",25,,add to survival plot
SCN1A,"sodium channel, voltage gated, type I alpha subunit",22 / 986 (2.23%),"641 / 10,202","34 / 1,072 (3.17%)","25 / 1,072 (2.33%)",24,,add to survival plot
NEDD9,"neural precursor cell expressed, developmentally down-regulated 9",22 / 986 (2.23%),"233 / 10,202","109 / 1,072 (10.17%)","41 / 1,072 (3.82%)",21,,add to survival plot
AKAP13,A kinase (PRKA) anchor protein 13,22 / 986 (2.23%),"475 / 10,202","85 / 1,072 (7.93%)","18 / 1,072 (1.68%)",28,,add to survival plot
SCN3A,"sodium channel, voltage gated, type III alpha subunit",22 / 986 (2.23%),"566 / 10,202","34 / 1,072 (3.17%)","21 / 1,072 (1.96%)",23,,add to survival plot
GRID1,"glutamate receptor, ionotropic, delta 1",22 / 986 (2.23%),"453 / 10,202","47 / 1,072 (4.38%)","57 / 1,072 (5.32%)",23,,add to survival plot
KIAA1549L,KIAA1549-like,22 / 986 (2.23%),"416 / 10,202","84 / 1,072 (7.84%)","8 / 1,072 (0.75%)",25,,add to survival plot
NALCN,"sodium leak channel, non selective",22 / 986 (2.23%),"658 / 10,202","101 / 1,072 (9.42%)","20 / 1,072 (1.87%)",25,,add to survival plot
CDK5RAP2,CDK5 regulatory subunit associated protein 2,22 / 986 (2.23%),"307 / 10,202","41 / 1,072 (3.82%)","30 / 1,072 (2.80%)",22,,add to survival plot
PTPRQ,"protein tyrosine phosphatase, receptor type, Q",22 / 986 (2.23%),"181 / 10,202","49 / 1,072 (4.57%)","50 / 1,072 (4.66%)",28,,add to survival plot
PLCB4,"phospholipase C, beta 4",22 / 986 (2.23%),"425 / 10,202","33 / 1,072 (3.08%)","57 / 1,072 (5.32%)",29,,add to survival plot
VWF,von Willebrand factor,22 / 986 (2.23%),"577 / 10,202","70 / 1,072 (6.53%)","47 / 1,072 (4.38%)",20,,add to survival plot
ARHGAP31,Rho GTPase activating protein 31,22 / 986 (2.23%),"354 / 10,202","37 / 1,072 (3.45%)","37 / 1,072 (3.45%)",22,,add to survival plot
DOCK4,dedicator of cytokinesis 4,22 / 986 (2.23%),"490 / 10,202","43 / 1,072 (4.01%)","43 / 1,072 (4.01%)",23,,add to survival plot
ALPK2,alpha-kinase 2,22 / 986 (2.23%),"496 / 10,202","30 / 1,072 (2.80%)","34 / 1,072 (3.17%)",26,,add to survival plot
MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",22 / 986 (2.23%),"426 / 10,202","21 / 1,072 (1.96%)","131 / 1,072 (12.22%)",23,,add to survival plot
EGFR,epidermal growth factor receptor,22 / 986 (2.23%),"548 / 10,202","44 / 1,072 (4.10%)","18 / 1,072 (1.68%)",22,Cancer Gene Census,add to survival plot
NPHP4,nephronophthisis 4,22 / 986 (2.23%),"307 / 10,202","28 / 1,072 (2.61%)","167 / 1,072 (15.58%)",24,,add to survival plot
AFF3,"AF4/FMR2 family, member 3",22 / 986 (2.23%),"405 / 10,202","51 / 1,072 (4.76%)","25 / 1,072 (2.33%)",25,Cancer Gene Census,add to survival plot
HDLBP,high density lipoprotein binding protein,22 / 986 (2.23%),"312 / 10,202","33 / 1,072 (3.08%)","98 / 1,072 (9.14%)",23,,add to survival plot
RLF,rearranged L-myc fusion,22 / 986 (2.23%),"286 / 10,202","63 / 1,072 (5.88%)","44 / 1,072 (4.10%)",24,,add to survival plot
FER1L5,fer-1-like family member 5,22 / 986 (2.23%),"246 / 10,202","49 / 1,072 (4.57%)","20 / 1,072 (1.87%)",23,,add to survival plot
TET3,tet methylcytosine dioxygenase 3,21 / 986 (2.13%),"335 / 10,202","44 / 1,072 (4.10%)","13 / 1,072 (1.21%)",22,,add to survival plot
ADGRB3,adhesion G protein-coupled receptor B3,21 / 986 (2.13%),"652 / 10,202","80 / 1,072 (7.46%)","60 / 1,072 (5.60%)",24,,add to survival plot
DSCAML1,Down syndrome cell adhesion molecule like 1,21 / 986 (2.13%),"566 / 10,202","23 / 1,072 (2.15%)","174 / 1,072 (16.23%)",22,,add to survival plot
TRPM2,"transient receptor potential cation channel, subfamily M, member 2",21 / 986 (2.13%),"421 / 10,202","72 / 1,072 (6.72%)","19 / 1,072 (1.77%)",22,,add to survival plot
SEC31A,SEC31 homolog A (S. cerevisiae),21 / 986 (2.13%),"264 / 10,202","43 / 1,072 (4.01%)","20 / 1,072 (1.87%)",19,,add to survival plot
ATAD2B,"ATPase family, AAA domain containing 2B",21 / 986 (2.13%),"231 / 10,202","36 / 1,072 (3.36%)","40 / 1,072 (3.73%)",23,,add to survival plot
KCNT2,"potassium channel, sodium activated subfamily T, member 2",21 / 986 (2.13%),"479 / 10,202","126 / 1,072 (11.75%)","22 / 1,072 (2.05%)",23,,add to survival plot
ASXL2,additional sex combs like transcriptional regulator 2,21 / 986 (2.13%),"333 / 10,202","37 / 1,072 (3.45%)","42 / 1,072 (3.92%)",25,,add to survival plot
PPP1R3A,"protein phosphatase 1, regulatory subunit 3A",21 / 986 (2.13%),"512 / 10,202","34 / 1,072 (3.17%)","41 / 1,072 (3.82%)",24,,add to survival plot
CHD2,chromodomain helicase DNA binding protein 2,21 / 986 (2.13%),"369 / 10,202","99 / 1,072 (9.24%)","14 / 1,072 (1.31%)",23,,add to survival plot
ARID2,"AT rich interactive domain 2 (ARID, RFX-like)",21 / 986 (2.13%),"510 / 10,202","40 / 1,072 (3.73%)","42 / 1,072 (3.92%)",24,Cancer Gene Census,add to survival plot
PHF20L1,PHD finger protein 20-like 1,21 / 986 (2.13%),"294 / 10,202","188 / 1,072 (17.54%)","40 / 1,072 (3.73%)",22,,add to survival plot
GCC2,GRIP and coiled-coil domain containing 2,21 / 986 (2.13%),"274 / 10,202","38 / 1,072 (3.54%)","25 / 1,072 (2.33%)",22,,add to survival plot
PTPRF,"protein tyrosine phosphatase, receptor type, F",21 / 986 (2.13%),"395 / 10,202","72 / 1,072 (6.72%)","40 / 1,072 (3.73%)",23,,add to survival plot
DIP2A,DIP2 disco-interacting protein 2 homolog A (Drosophila),21 / 986 (2.13%),"339 / 10,202","79 / 1,072 (7.37%)","21 / 1,072 (1.96%)",22,,add to survival plot
COL4A4,"collagen, type IV, alpha 4",21 / 986 (2.13%),"492 / 10,202","30 / 1,072 (2.80%)","69 / 1,072 (6.44%)",22,,add to survival plot
PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",21 / 986 (2.13%),"481 / 10,202","47 / 1,072 (4.38%)","32 / 1,072 (2.99%)",22,,add to survival plot
ITGAX,"integrin, alpha X (complement component 3 receptor 4 subunit)",21 / 986 (2.13%),"393 / 10,202","63 / 1,072 (5.88%)","12 / 1,072 (1.12%)",24,,add to survival plot
HELZ,helicase with zinc finger,21 / 986 (2.13%),"356 / 10,202","245 / 1,072 (22.85%)","10 / 1,072 (0.93%)",26,,add to survival plot
LAMA4,"laminin, alpha 4",21 / 986 (2.13%),"439 / 10,202","59 / 1,072 (5.50%)","65 / 1,072 (6.06%)",24,,add to survival plot
SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",21 / 986 (2.13%),"327 / 10,202","90 / 1,072 (8.40%)","10 / 1,072 (0.93%)",25,,add to survival plot
UGGT2,UDP-glucose glycoprotein glucosyltransferase 2,21 / 986 (2.13%),"313 / 10,202","96 / 1,072 (8.96%)","21 / 1,072 (1.96%)",23,,add to survival plot
PCDH11X,protocadherin 11 X-linked,21 / 986 (2.13%),"704 / 10,202","18 / 1,072 (1.68%)","30 / 1,072 (2.80%)",21,,add to survival plot
HECW2,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2",21 / 986 (2.13%),"437 / 10,202","59 / 1,072 (5.50%)","22 / 1,072 (2.05%)",24,,add to survival plot
C2orf71,chromosome 2 open reading frame 71,21 / 986 (2.13%),"332 / 10,202","46 / 1,072 (4.29%)","21 / 1,072 (1.96%)",22,,add to survival plot
FAM186A,"family with sequence similarity 186, member A",21 / 986 (2.13%),"156 / 10,202","36 / 1,072 (3.36%)","46 / 1,072 (4.29%)",27,,add to survival plot
NIN,ninein (GSK3B interacting protein),21 / 986 (2.13%),"364 / 10,202","86 / 1,072 (8.02%)","20 / 1,072 (1.87%)",26,Cancer Gene Census,add to survival plot
IQGAP3,IQ motif containing GTPase activating protein 3,21 / 986 (2.13%),"307 / 10,202","150 / 1,072 (13.99%)","27 / 1,072 (2.52%)",22,,add to survival plot
RALGAPA2,"Ral GTPase activating protein, alpha subunit 2 (catalytic)",21 / 986 (2.13%),"328 / 10,202","35 / 1,072 (3.26%)","32 / 1,072 (2.99%)",23,,add to survival plot
WNK1,WNK lysine deficient protein kinase 1,21 / 986 (2.13%),"411 / 10,202","93 / 1,072 (8.68%)","48 / 1,072 (4.48%)",24,,add to survival plot
EML5,echinoderm microtubule associated protein like 5,21 / 986 (2.13%),"300 / 10,202","35 / 1,072 (3.26%)","71 / 1,072 (6.62%)",22,,add to survival plot
POLQ,"polymerase (DNA directed), theta",21 / 986 (2.13%),"495 / 10,202","34 / 1,072 (3.17%)","38 / 1,072 (3.54%)",21,,add to survival plot
SPTBN2,"spectrin, beta, non-erythrocytic 2",21 / 986 (2.13%),"384 / 10,202","197 / 1,072 (18.38%)","22 / 1,072 (2.05%)",21,,add to survival plot
DLC1,DLC1 Rho GTPase activating protein,21 / 986 (2.13%),"469 / 10,202","26 / 1,072 (2.43%)","78 / 1,072 (7.28%)",22,,add to survival plot
UMODL1,uromodulin-like 1,21 / 986 (2.13%),"324 / 10,202","68 / 1,072 (6.34%)","15 / 1,072 (1.40%)",25,,add to survival plot
SZT2,seizure threshold 2 homolog (mouse),21 / 986 (2.13%),"528 / 10,202","70 / 1,072 (6.53%)","39 / 1,072 (3.64%)",30,,add to survival plot
DLG1,"discs, large homolog 1 (Drosophila)",21 / 986 (2.13%),"196 / 10,202","136 / 1,072 (12.69%)","34 / 1,072 (3.17%)",23,,add to survival plot
RPGR,retinitis pigmentosa GTPase regulator,21 / 986 (2.13%),"214 / 10,202","15 / 1,072 (1.40%)","19 / 1,072 (1.77%)",24,,add to survival plot
CTNNA2,"catenin (cadherin-associated protein), alpha 2",21 / 986 (2.13%),"565 / 10,202","52 / 1,072 (4.85%)","26 / 1,072 (2.43%)",21,,add to survival plot
NFASC,neurofascin,21 / 986 (2.13%),"501 / 10,202","175 / 1,072 (16.32%)","10 / 1,072 (0.93%)",23,,add to survival plot
KIF5C,kinesin family member 5C,21 / 986 (2.13%),"255 / 10,202","20 / 1,072 (1.87%)","41 / 1,072 (3.82%)",22,,add to survival plot
CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",21 / 986 (2.13%),"361 / 10,202","42 / 1,072 (3.92%)","35 / 1,072 (3.26%)",24,,add to survival plot
CCNB3,cyclin B3,21 / 986 (2.13%),"356 / 10,202","34 / 1,072 (3.17%)","9 / 1,072 (0.84%)",25,,add to survival plot
MADD,MAP-kinase activating death domain,21 / 986 (2.13%),"316 / 10,202","63 / 1,072 (5.88%)","17 / 1,072 (1.59%)",22,,add to survival plot
FCRL5,Fc receptor-like 5,21 / 986 (2.13%),"419 / 10,202","145 / 1,072 (13.53%)","29 / 1,072 (2.71%)",21,,add to survival plot
GRID2,"glutamate receptor, ionotropic, delta 2",21 / 986 (2.13%),"517 / 10,202","47 / 1,072 (4.38%)","36 / 1,072 (3.36%)",16,,add to survival plot
ABCA9,"ATP-binding cassette, sub-family A (ABC1), member 9",21 / 986 (2.13%),"363 / 10,202","233 / 1,072 (21.74%)","19 / 1,072 (1.77%)",24,,add to survival plot
MAP3K4,mitogen-activated protein kinase kinase kinase 4,21 / 986 (2.13%),"348 / 10,202","51 / 1,072 (4.76%)","101 / 1,072 (9.42%)",22,,add to survival plot
CTTNBP2,cortactin binding protein 2,21 / 986 (2.13%),"407 / 10,202","43 / 1,072 (4.01%)","35 / 1,072 (3.26%)",21,,add to survival plot
TBC1D4,"TBC1 domain family, member 4",21 / 986 (2.13%),"262 / 10,202","55 / 1,072 (5.13%)","35 / 1,072 (3.26%)",21,,add to survival plot
MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,21 / 986 (2.13%),"294 / 10,202","37 / 1,072 (3.45%)","24 / 1,072 (2.24%)",23,,add to survival plot
TANC2,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2",21 / 986 (2.13%),"324 / 10,202","243 / 1,072 (22.67%)","18 / 1,072 (1.68%)",24,,add to survival plot
ANKRD26,ankyrin repeat domain 26,21 / 986 (2.13%),"324 / 10,202","30 / 1,072 (2.80%)","24 / 1,072 (2.24%)",23,,add to survival plot
KIAA0232,KIAA0232,21 / 986 (2.13%),"251 / 10,202","36 / 1,072 (3.36%)","30 / 1,072 (2.80%)",25,,add to survival plot
CNTNAP2,contactin associated protein-like 2,21 / 986 (2.13%),"707 / 10,202","60 / 1,072 (5.60%)","77 / 1,072 (7.18%)",22,,add to survival plot
NBEA,neurobeachin,21 / 986 (2.13%),"605 / 10,202","64 / 1,072 (5.97%)","93 / 1,072 (8.68%)",26,,add to survival plot
EPG5,ectopic P-granules autophagy protein 5 homolog (C. elegans),21 / 986 (2.13%),"409 / 10,202","27 / 1,072 (2.52%)","25 / 1,072 (2.33%)",24,,add to survival plot
WDR87,WD repeat domain 87,21 / 986 (2.13%),"250 / 10,202","73 / 1,072 (6.81%)","19 / 1,072 (1.77%)",30,,add to survival plot
PLEKHH2,"pleckstrin homology domain containing, family H (with MyTH4 domain) member 2",21 / 986 (2.13%),"337 / 10,202","38 / 1,072 (3.54%)","23 / 1,072 (2.15%)",22,,add to survival plot
NAV1,neuron navigator 1,21 / 986 (2.13%),"354 / 10,202","150 / 1,072 (13.99%)","12 / 1,072 (1.12%)",22,,add to survival plot
RANBP2,RAN binding protein 2,21 / 986 (2.13%),"505 / 10,202","36 / 1,072 (3.36%)","26 / 1,072 (2.43%)",25,Cancer Gene Census,add to survival plot
EP400,E1A binding protein p400,21 / 986 (2.13%),"541 / 10,202","36 / 1,072 (3.36%)","83 / 1,072 (7.74%)",21,,add to survival plot
GOLGA6L9,golgin A6 family-like 9,21 / 986 (2.13%),"202 / 10,202","77 / 1,072 (7.18%)","16 / 1,072 (1.49%)",17,,add to survival plot
CEP250,centrosomal protein 250kDa,21 / 986 (2.13%),"353 / 10,202","57 / 1,072 (5.32%)","29 / 1,072 (2.71%)",22,,add to survival plot
CECR2,"cat eye syndrome chromosome region, candidate 2",21 / 986 (2.13%),"309 / 10,202","62 / 1,072 (5.78%)","47 / 1,072 (4.38%)",24,,add to survival plot
SEC16B,SEC16 homolog B (S. cerevisiae),21 / 986 (2.13%),"270 / 10,202","114 / 1,072 (10.63%)","32 / 1,072 (2.99%)",23,,add to survival plot
URB1,URB1 ribosome biogenesis 1 homolog (S. cerevisiae),21 / 986 (2.13%),"181 / 10,202","44 / 1,072 (4.10%)","20 / 1,072 (1.87%)",22,,add to survival plot
FBN2,fibrillin 2,21 / 986 (2.13%),"705 / 10,202","30 / 1,072 (2.80%)","41 / 1,072 (3.82%)",25,,add to survival plot
GRIK1,"glutamate receptor, ionotropic, kainate 1",21 / 986 (2.13%),"326 / 10,202","33 / 1,072 (3.08%)","32 / 1,072 (2.99%)",22,,add to survival plot
RIF1,replication timing regulatory factor 1,21 / 986 (2.13%),"397 / 10,202","21 / 1,072 (1.96%)","38 / 1,072 (3.54%)",21,,add to survival plot
MYH4,"myosin, heavy chain 4, skeletal muscle",21 / 986 (2.13%),"616 / 10,202","11 / 1,072 (1.03%)","32 / 1,072 (2.99%)",23,,add to survival plot
SPATA31D1,"SPATA31 subfamily D, member 1",21 / 986 (2.13%),"474 / 10,202","27 / 1,072 (2.52%)","32 / 1,072 (2.99%)",23,,add to survival plot
ANXA8,annexin A8,21 / 986 (2.13%),"209 / 10,202","41 / 1,072 (3.82%)","34 / 1,072 (3.17%)",11,,add to survival plot
SON,SON DNA binding protein,21 / 986 (2.13%),"366 / 10,202","51 / 1,072 (4.76%)","13 / 1,072 (1.21%)",26,,add to survival plot
NLGN4X,"neuroligin 4, X-linked",20 / 986 (2.03%),"432 / 10,202","42 / 1,072 (3.92%)","33 / 1,072 (3.08%)",19,,add to survival plot
CNTLN,"centlein, centrosomal protein",20 / 986 (2.03%),"322 / 10,202","46 / 1,072 (4.29%)","30 / 1,072 (2.80%)",21,,add to survival plot
MTUS2,microtubule associated tumor suppressor candidate 2,20 / 986 (2.03%),"527 / 10,202","107 / 1,072 (9.98%)","73 / 1,072 (6.81%)",21,,add to survival plot
SBF2,SET binding factor 2,20 / 986 (2.03%),"322 / 10,202","36 / 1,072 (3.36%)","72 / 1,072 (6.72%)",22,,add to survival plot
PHIP,pleckstrin homology domain interacting protein,20 / 986 (2.03%),"292 / 10,202","48 / 1,072 (4.48%)","69 / 1,072 (6.44%)",23,,add to survival plot
PDE3A,"phosphodiesterase 3A, cGMP-inhibited",20 / 986 (2.03%),"406 / 10,202","42 / 1,072 (3.92%)","40 / 1,072 (3.73%)",21,,add to survival plot
CCDC88A,coiled-coil domain containing 88A,20 / 986 (2.03%),"326 / 10,202","55 / 1,072 (5.13%)","6 / 1,072 (0.56%)",28,,add to survival plot
SPAG17,sperm associated antigen 17,20 / 986 (2.03%),"529 / 10,202","65 / 1,072 (6.06%)","62 / 1,072 (5.78%)",24,,add to survival plot
LRRK1,leucine-rich repeat kinase 1,20 / 986 (2.03%),"394 / 10,202","104 / 1,072 (9.70%)","28 / 1,072 (2.61%)",23,,add to survival plot
ADCY8,adenylate cyclase 8 (brain),20 / 986 (2.03%),"577 / 10,202","195 / 1,072 (18.19%)","36 / 1,072 (3.36%)",20,,add to survival plot
CNTRL,centriolin,20 / 986 (2.03%),"321 / 10,202","44 / 1,072 (4.10%)","27 / 1,072 (2.52%)",26,Cancer Gene Census,add to survival plot
NOS1,nitric oxide synthase 1 (neuronal),20 / 986 (2.03%),"562 / 10,202","39 / 1,072 (3.64%)","80 / 1,072 (7.46%)",23,,add to survival plot
NWD1,NACHT and WD repeat domain containing 1,20 / 986 (2.03%),"397 / 10,202","55 / 1,072 (5.13%)","18 / 1,072 (1.68%)",20,,add to survival plot
FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",20 / 986 (2.03%),"562 / 10,202","51 / 1,072 (4.76%)","45 / 1,072 (4.20%)",19,Cancer Gene Census,add to survival plot
TSHZ2,teashirt zinc finger homeobox 2,20 / 986 (2.03%),"446 / 10,202","153 / 1,072 (14.27%)","17 / 1,072 (1.59%)",20,,add to survival plot
LAMB4,"laminin, beta 4",20 / 986 (2.03%),"423 / 10,202","34 / 1,072 (3.17%)","40 / 1,072 (3.73%)",21,,add to survival plot
UNC13A,unc-13 homolog A (C. elegans),20 / 986 (2.03%),"367 / 10,202","54 / 1,072 (5.04%)","18 / 1,072 (1.68%)",21,,add to survival plot
SPTBN1,"spectrin, beta, non-erythrocytic 1",20 / 986 (2.03%),"452 / 10,202","56 / 1,072 (5.22%)","7 / 1,072 (0.65%)",20,,add to survival plot
NID1,nidogen 1,20 / 986 (2.03%),"336 / 10,202","167 / 1,072 (15.58%)","33 / 1,072 (3.08%)",21,,add to survival plot
CDH9,"cadherin 9, type 2 (T1-cadherin)",20 / 986 (2.03%),"596 / 10,202","62 / 1,072 (5.78%)","15 / 1,072 (1.40%)",21,,add to survival plot
FMNL3,formin-like 3,20 / 986 (2.03%),"261 / 10,202","31 / 1,072 (2.89%)","48 / 1,072 (4.48%)",20,,add to survival plot
WDR44,WD repeat domain 44,20 / 986 (2.03%),"255 / 10,202","38 / 1,072 (3.54%)","25 / 1,072 (2.33%)",21,,add to survival plot
ZC3H12B,zinc finger CCCH-type containing 12B,20 / 986 (2.03%),"250 / 10,202","39 / 1,072 (3.64%)","14 / 1,072 (1.31%)",18,,add to survival plot
MYO7B,myosin VIIB,20 / 986 (2.03%),"479 / 10,202","19 / 1,072 (1.77%)","39 / 1,072 (3.64%)",21,,add to survival plot
TLR4,toll-like receptor 4,20 / 986 (2.03%),"410 / 10,202","41 / 1,072 (3.82%)","33 / 1,072 (3.08%)",24,,add to survival plot
HCFC1,host cell factor C1,20 / 986 (2.03%),"352 / 10,202","69 / 1,072 (6.44%)","26 / 1,072 (2.43%)",22,,add to survival plot
PCNX,pecanex homolog (Drosophila),20 / 986 (2.03%),"386 / 10,202","15 / 1,072 (1.40%)","80 / 1,072 (7.46%)",23,,add to survival plot
POGZ,pogo transposable element with ZNF domain,20 / 986 (2.03%),"273 / 10,202","191 / 1,072 (17.82%)","22 / 1,072 (2.05%)",20,,add to survival plot
UNC79,unc-79 homolog (C. elegans),20 / 986 (2.03%),"668 / 10,202","40 / 1,072 (3.73%)","69 / 1,072 (6.44%)",23,,add to survival plot
KCNB2,"potassium channel, voltage gated Shab related subfamily B, member 2",20 / 986 (2.03%),"519 / 10,202","113 / 1,072 (10.54%)","42 / 1,072 (3.92%)",21,,add to survival plot
ADAMTS20,"ADAM metallopeptidase with thrombospondin type 1 motif, 20",20 / 986 (2.03%),"550 / 10,202","58 / 1,072 (5.41%)","30 / 1,072 (2.80%)",24,,add to survival plot
FANCD2,"Fanconi anemia, complementation group D2",20 / 986 (2.03%),"302 / 10,202","96 / 1,072 (8.96%)","25 / 1,072 (2.33%)",21,Cancer Gene Census,add to survival plot
ERBB4,erb-b2 receptor tyrosine kinase 4,20 / 986 (2.03%),"595 / 10,202","53 / 1,072 (4.94%)","51 / 1,072 (4.76%)",22,Cancer Gene Census,add to survival plot
PKDREJ,polycystin (PKD) family receptor for egg jelly,20 / 986 (2.03%),"390 / 10,202","33 / 1,072 (3.08%)","47 / 1,072 (4.38%)",32,,add to survival plot
CAMSAP1,calmodulin regulated spectrin-associated protein 1,20 / 986 (2.03%),"285 / 10,202","51 / 1,072 (4.76%)","41 / 1,072 (3.82%)",26,,add to survival plot
NRK,Nik related kinase,20 / 986 (2.03%),"479 / 10,202","14 / 1,072 (1.31%)","28 / 1,072 (2.61%)",20,,add to survival plot
MED23,mediator complex subunit 23,20 / 986 (2.03%),"262 / 10,202","74 / 1,072 (6.90%)","41 / 1,072 (3.82%)",19,,add to survival plot
RAD54B,RAD54 homolog B (S. cerevisiae),20 / 986 (2.03%),"177 / 10,202","180 / 1,072 (16.79%)","19 / 1,072 (1.77%)",22,,add to survival plot
WWP2,WW domain containing E3 ubiquitin protein ligase 2,20 / 986 (2.03%),"214 / 10,202","40 / 1,072 (3.73%)","40 / 1,072 (3.73%)",21,,add to survival plot
SCN11A,"sodium channel, voltage gated, type XI alpha subunit",20 / 986 (2.03%),"548 / 10,202","33 / 1,072 (3.08%)","81 / 1,072 (7.56%)",22,,add to survival plot
SRGAP2,SLIT-ROBO Rho GTPase activating protein 2,20 / 986 (2.03%),"182 / 10,202","161 / 1,072 (15.02%)","14 / 1,072 (1.31%)",19,,add to survival plot
CYFIP1,cytoplasmic FMR1 interacting protein 1,20 / 986 (2.03%),"274 / 10,202","52 / 1,072 (4.85%)","100 / 1,072 (9.33%)",20,,add to survival plot
ANO4,anoctamin 4,20 / 986 (2.03%),"420 / 10,202","35 / 1,072 (3.26%)","63 / 1,072 (5.88%)",23,,add to survival plot
PRKG2,"protein kinase, cGMP-dependent, type II",20 / 986 (2.03%),"237 / 10,202","50 / 1,072 (4.66%)","20 / 1,072 (1.87%)",20,,add to survival plot
LAMA5,"laminin, alpha 5",20 / 986 (2.03%),"514 / 10,202","134 / 1,072 (12.50%)","30 / 1,072 (2.80%)",21,,add to survival plot
AFF1,"AF4/FMR2 family, member 1",20 / 986 (2.03%),"284 / 10,202","44 / 1,072 (4.10%)","23 / 1,072 (2.15%)",21,Cancer Gene Census,add to survival plot
BRINP3,bone morphogenetic protein/retinoic acid inducible neural-specific 3,20 / 986 (2.03%),"569 / 10,202","122 / 1,072 (11.38%)","25 / 1,072 (2.33%)",21,,add to survival plot
TNN,tenascin N,20 / 986 (2.03%),"551 / 10,202","111 / 1,072 (10.35%)","33 / 1,072 (3.08%)",22,,add to survival plot
RB1CC1,RB1-inducible coiled-coil 1,20 / 986 (2.03%),"347 / 10,202","87 / 1,072 (8.12%)","66 / 1,072 (6.16%)",25,,add to survival plot
C2CD3,C2 calcium-dependent domain containing 3,20 / 986 (2.03%),"340 / 10,202","159 / 1,072 (14.83%)","43 / 1,072 (4.01%)",21,,add to survival plot
ADGB,androglobin,20 / 986 (2.03%),"267 / 10,202","60 / 1,072 (5.60%)","67 / 1,072 (6.25%)",23,,add to survival plot
SHANK1,SH3 and multiple ankyrin repeat domains 1,20 / 986 (2.03%),"414 / 10,202","66 / 1,072 (6.16%)","42 / 1,072 (3.92%)",23,,add to survival plot
ADCY10,adenylate cyclase 10 (soluble),20 / 986 (2.03%),"370 / 10,202","132 / 1,072 (12.31%)","28 / 1,072 (2.61%)",22,,add to survival plot
PTPRT,"protein tyrosine phosphatase, receptor type, T",20 / 986 (2.03%),"720 / 10,202","70 / 1,072 (6.53%)","49 / 1,072 (4.57%)",23,,add to survival plot
FNDC1,fibronectin type III domain containing 1,20 / 986 (2.03%),"486 / 10,202","58 / 1,072 (5.41%)","95 / 1,072 (8.86%)",22,,add to survival plot
HIVEP3,human immunodeficiency virus type I enhancer binding protein 3,20 / 986 (2.03%),"481 / 10,202","72 / 1,072 (6.72%)","41 / 1,072 (3.82%)",25,,add to survival plot
CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",20 / 986 (2.03%),"457 / 10,202","14 / 1,072 (1.31%)","142 / 1,072 (13.25%)",22,Cancer Gene Census,add to survival plot
ANKHD1-EIF4EBP3,ANKHD1-EIF4EBP3 readthrough,20 / 986 (2.03%),"388 / 10,202","50 / 1,072 (4.66%)","22 / 1,072 (2.05%)",21,,add to survival plot
ROBO1,"roundabout, axon guidance receptor, homolog 1 (Drosophila)",20 / 986 (2.03%),"496 / 10,202","38 / 1,072 (3.54%)","101 / 1,072 (9.42%)",24,,add to survival plot
HECTD1,HECT domain containing E3 ubiquitin protein ligase 1,20 / 986 (2.03%),"349 / 10,202","93 / 1,072 (8.68%)","17 / 1,072 (1.59%)",23,,add to survival plot
PTPRZ1,"protein tyrosine phosphatase, receptor-type, Z polypeptide 1",20 / 986 (2.03%),"538 / 10,202","42 / 1,072 (3.92%)","39 / 1,072 (3.64%)",22,,add to survival plot
TEP1,telomerase-associated protein 1,20 / 986 (2.03%),"416 / 10,202","89 / 1,072 (8.30%)","28 / 1,072 (2.61%)",21,,add to survival plot
TAB3,TGF-beta activated kinase 1/MAP3K7 binding protein 3,20 / 986 (2.03%),"240 / 10,202","26 / 1,072 (2.43%)","15 / 1,072 (1.40%)",22,,add to survival plot
DOCK9,dedicator of cytokinesis 9,20 / 986 (2.03%),"344 / 10,202","103 / 1,072 (9.61%)","20 / 1,072 (1.87%)",24,,add to survival plot
ZSWIM8,"zinc finger, SWIM-type containing 8",20 / 986 (2.03%),"306 / 10,202","65 / 1,072 (6.06%)","24 / 1,072 (2.24%)",22,,add to survival plot
POTEH,"POTE ankyrin domain family, member H",20 / 986 (2.03%),"457 / 10,202","59 / 1,072 (5.50%)","48 / 1,072 (4.48%)",20,,add to survival plot
DNMT1,DNA (cytosine-5-)-methyltransferase 1,20 / 986 (2.03%),"290 / 10,202","54 / 1,072 (5.04%)","36 / 1,072 (3.36%)",21,,add to survival plot
FRMPD3,FERM and PDZ domain containing 3,20 / 986 (2.03%),"347 / 10,202","19 / 1,072 (1.77%)","24 / 1,072 (2.24%)",10,,add to survival plot
BCORL1,BCL6 corepressor-like 1,20 / 986 (2.03%),"428 / 10,202","42 / 1,072 (3.92%)","19 / 1,072 (1.77%)",20,,add to survival plot
COPA,"coatomer protein complex, subunit alpha",20 / 986 (2.03%),"301 / 10,202","153 / 1,072 (14.27%)","22 / 1,072 (2.05%)",22,,add to survival plot
GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",20 / 986 (2.03%),"561 / 10,202","35 / 1,072 (3.26%)","69 / 1,072 (6.44%)",20,,add to survival plot
TTC28,tetratricopeptide repeat domain 28,20 / 986 (2.03%),"183 / 10,202","47 / 1,072 (4.38%)","28 / 1,072 (2.61%)",23,,add to survival plot
DIP2C,DIP2 disco-interacting protein 2 homolog C (Drosophila),20 / 986 (2.03%),"367 / 10,202","112 / 1,072 (10.45%)","33 / 1,072 (3.08%)",23,,add to survival plot
EXPH5,exophilin 5,20 / 986 (2.03%),"383 / 10,202","33 / 1,072 (3.08%)","156 / 1,072 (14.55%)",21,,add to survival plot
GREB1L,growth regulation by estrogen in breast cancer-like,20 / 986 (2.03%),"148 / 10,202","36 / 1,072 (3.36%)","18 / 1,072 (1.68%)",21,,add to survival plot
RBFOX1,"RNA binding protein, fox-1 homolog (C. elegans) 1",20 / 986 (2.03%),"387 / 10,202","78 / 1,072 (7.28%)","28 / 1,072 (2.61%)",20,,add to survival plot
TECTA,tectorin alpha,20 / 986 (2.03%),"572 / 10,202","23 / 1,072 (2.15%)","158 / 1,072 (14.74%)",20,,add to survival plot
SORCS1,sortilin-related VPS10 domain containing receptor 1,20 / 986 (2.03%),"576 / 10,202","28 / 1,072 (2.61%)","91 / 1,072 (8.49%)",21,,add to survival plot
ZNFX1,"zinc finger, NFX1-type containing 1",20 / 986 (2.03%),"348 / 10,202","100 / 1,072 (9.33%)","32 / 1,072 (2.99%)",23,,add to survival plot
KDM5A,lysine (K)-specific demethylase 5A,20 / 986 (2.03%),"366 / 10,202","91 / 1,072 (8.49%)","48 / 1,072 (4.48%)",20,Cancer Gene Census,add to survival plot
ABCA3,"ATP-binding cassette, sub-family A (ABC1), member 3",20 / 986 (2.03%),"367 / 10,202","85 / 1,072 (7.93%)","16 / 1,072 (1.49%)",24,,add to survival plot
GRM3,"glutamate receptor, metabotropic 3",20 / 986 (2.03%),"516 / 10,202","37 / 1,072 (3.45%)","27 / 1,072 (2.52%)",22,,add to survival plot
SDK2,sidekick cell adhesion molecule 2,20 / 986 (2.03%),"436 / 10,202","228 / 1,072 (21.27%)","25 / 1,072 (2.33%)",25,,add to survival plot
OTOF,otoferlin,20 / 986 (2.03%),"490 / 10,202","41 / 1,072 (3.82%)","33 / 1,072 (3.08%)",20,,add to survival plot
ZMYM3,"zinc finger, MYM-type 3",20 / 986 (2.03%),"315 / 10,202","23 / 1,072 (2.15%)","22 / 1,072 (2.05%)",21,,add to survival plot
PLXNA3,plexin A3,20 / 986 (2.03%),"363 / 10,202","68 / 1,072 (6.34%)","27 / 1,072 (2.52%)",23,,add to survival plot
IGSF1,"immunoglobulin superfamily, member 1",20 / 986 (2.03%),"449 / 10,202","45 / 1,072 (4.20%)","17 / 1,072 (1.59%)",23,,add to survival plot
UNC80,unc-80 homolog (C. elegans),20 / 986 (2.03%),"361 / 10,202","40 / 1,072 (3.73%)","37 / 1,072 (3.45%)",21,,add to survival plot
ZFC3H1,"zinc finger, C3H1-type containing",20 / 986 (2.03%),"346 / 10,202","84 / 1,072 (7.84%)","19 / 1,072 (1.77%)",22,,add to survival plot
PCDHB7,protocadherin beta 7,19 / 986 (1.93%),"523 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",22,,add to survival plot
CHD5,chromodomain helicase DNA binding protein 5,19 / 986 (1.93%),"493 / 10,202","27 / 1,072 (2.52%)","167 / 1,072 (15.58%)",20,,add to survival plot
CCDC150,coiled-coil domain containing 150,19 / 986 (1.93%),"247 / 10,202","59 / 1,072 (5.50%)","19 / 1,072 (1.77%)",22,,add to survival plot
IQSEC2,IQ motif and Sec7 domain 2,19 / 986 (1.93%),"263 / 10,202","36 / 1,072 (3.36%)","12 / 1,072 (1.12%)",21,,add to survival plot
BRINP1,bone morphogenetic protein/retinoic acid inducible neural-specific 1,19 / 986 (1.93%),"448 / 10,202","35 / 1,072 (3.26%)","31 / 1,072 (2.89%)",19,,add to survival plot
EML6,echinoderm microtubule associated protein like 6,19 / 986 (1.93%),"167 / 10,202","58 / 1,072 (5.41%)","10 / 1,072 (0.93%)",21,,add to survival plot
ADGRL3,adhesion G protein-coupled receptor L3,19 / 986 (1.93%),"588 / 10,202","74 / 1,072 (6.90%)","16 / 1,072 (1.49%)",20,,add to survival plot
DNMBP,dynamin binding protein,19 / 986 (1.93%),"269 / 10,202","31 / 1,072 (2.89%)","70 / 1,072 (6.53%)",18,,add to survival plot
KIAA0430,KIAA0430,19 / 986 (1.93%),"308 / 10,202","61 / 1,072 (5.69%)","9 / 1,072 (0.84%)",21,,add to survival plot
MROH9,maestro heat-like repeat family member 9,19 / 986 (1.93%),"278 / 10,202","116 / 1,072 (10.82%)","33 / 1,072 (3.08%)",16,,add to survival plot
THADA,thyroid adenoma associated,19 / 986 (1.93%),"288 / 10,202","41 / 1,072 (3.82%)","32 / 1,072 (2.99%)",23,,add to survival plot
MYT1L,myelin transcription factor 1-like,19 / 986 (1.93%),"521 / 10,202","54 / 1,072 (5.04%)","39 / 1,072 (3.64%)",21,,add to survival plot
MCTP2,"multiple C2 domains, transmembrane 2",19 / 986 (1.93%),"299 / 10,202","102 / 1,072 (9.51%)","21 / 1,072 (1.96%)",19,,add to survival plot
SMARCC1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1",19 / 986 (1.93%),"210 / 10,202","16 / 1,072 (1.49%)","141 / 1,072 (13.15%)",20,,add to survival plot
SAMD9,sterile alpha motif domain containing 9,19 / 986 (1.93%),"428 / 10,202","41 / 1,072 (3.82%)","25 / 1,072 (2.33%)",20,,add to survival plot
PTPRG,"protein tyrosine phosphatase, receptor type, G",19 / 986 (1.93%),"342 / 10,202","18 / 1,072 (1.68%)","135 / 1,072 (12.59%)",22,,add to survival plot
RGPD3,RANBP2-like and GRIP domain containing 3,19 / 986 (1.93%),"397 / 10,202","36 / 1,072 (3.36%)","25 / 1,072 (2.33%)",20,,add to survival plot
CELSR2,"cadherin, EGF LAG seven-pass G-type receptor 2",19 / 986 (1.93%),"456 / 10,202","50 / 1,072 (4.66%)","91 / 1,072 (8.49%)",28,,add to survival plot
PIK3C2B,"phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta",19 / 986 (1.93%),"359 / 10,202","170 / 1,072 (15.86%)","7 / 1,072 (0.65%)",23,,add to survival plot
DGKD,"diacylglycerol kinase, delta 130kDa",19 / 986 (1.93%),"273 / 10,202","22 / 1,072 (2.05%)","80 / 1,072 (7.46%)",20,,add to survival plot
SYBU,syntabulin (syntaxin-interacting),19 / 986 (1.93%),"218 / 10,202","190 / 1,072 (17.72%)","12 / 1,072 (1.12%)",20,,add to survival plot
TMEM131,transmembrane protein 131,19 / 986 (1.93%),"296 / 10,202","48 / 1,072 (4.48%)","19 / 1,072 (1.77%)",21,,add to survival plot
SPATA31D5P,"SPATA31 subfamily D, member 5, pseudogene",19 / 986 (1.93%),"376 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",19,,add to survival plot
TNR,tenascin R,19 / 986 (1.93%),"646 / 10,202","115 / 1,072 (10.73%)","31 / 1,072 (2.89%)",21,,add to survival plot
ZNF217,zinc finger protein 217,19 / 986 (1.93%),"317 / 10,202","157 / 1,072 (14.65%)","8 / 1,072 (0.75%)",17,,add to survival plot
BCR,breakpoint cluster region,19 / 986 (1.93%),"330 / 10,202","58 / 1,072 (5.41%)","30 / 1,072 (2.80%)",17,Cancer Gene Census,add to survival plot
VCAN,versican,19 / 986 (1.93%),"667 / 10,202","13 / 1,072 (1.21%)","56 / 1,072 (5.22%)",24,,add to survival plot
CHD3,chromodomain helicase DNA binding protein 3,19 / 986 (1.93%),"365 / 10,202","18 / 1,072 (1.68%)","38 / 1,072 (3.54%)",23,,add to survival plot
WSCD2,WSC domain containing 2,19 / 986 (1.93%),"302 / 10,202","33 / 1,072 (3.08%)","71 / 1,072 (6.62%)",21,,add to survival plot
CNTNAP3,contactin associated protein-like 3,19 / 986 (1.93%),"366 / 10,202","60 / 1,072 (5.60%)","44 / 1,072 (4.10%)",20,,add to survival plot
CDH10,"cadherin 10, type 2 (T2-cadherin)",19 / 986 (1.93%),"649 / 10,202","70 / 1,072 (6.53%)","16 / 1,072 (1.49%)",20,,add to survival plot
ESPL1,extra spindle pole bodies homolog 1 (S. cerevisiae),19 / 986 (1.93%),"348 / 10,202","30 / 1,072 (2.80%)","50 / 1,072 (4.66%)",19,,add to survival plot
TRIOBP,TRIO and F-actin binding protein,19 / 986 (1.93%),"462 / 10,202","28 / 1,072 (2.61%)","21 / 1,072 (1.96%)",19,,add to survival plot
CCDC180,coiled-coil domain containing 180,19 / 986 (1.93%),"296 / 10,202","27 / 1,072 (2.52%)","42 / 1,072 (3.92%)",21,,add to survival plot
ATP11C,"ATPase, class VI, type 11C",19 / 986 (1.93%),"305 / 10,202","60 / 1,072 (5.60%)","23 / 1,072 (2.15%)",19,,add to survival plot
PIKFYVE,"phosphoinositide kinase, FYVE finger containing",19 / 986 (1.93%),"389 / 10,202","44 / 1,072 (4.10%)","37 / 1,072 (3.45%)",20,,add to survival plot
COL5A3,"collagen, type V, alpha 3",19 / 986 (1.93%),"439 / 10,202","50 / 1,072 (4.66%)","40 / 1,072 (3.73%)",21,,add to survival plot
COL4A6,"collagen, type IV, alpha 6",19 / 986 (1.93%),"382 / 10,202","21 / 1,072 (1.96%)","27 / 1,072 (2.52%)",21,,add to survival plot
STAG1,stromal antigen 1,19 / 986 (1.93%),"313 / 10,202","65 / 1,072 (6.06%)","36 / 1,072 (3.36%)",27,,add to survival plot
CACNA1G,"calcium channel, voltage-dependent, T type, alpha 1G subunit",19 / 986 (1.93%),"480 / 10,202","167 / 1,072 (15.58%)","19 / 1,072 (1.77%)",27,,add to survival plot
SPTBN4,"spectrin, beta, non-erythrocytic 4",19 / 986 (1.93%),"449 / 10,202","47 / 1,072 (4.38%)","39 / 1,072 (3.64%)",20,,add to survival plot
CELSR1,"cadherin, EGF LAG seven-pass G-type receptor 1",19 / 986 (1.93%),"517 / 10,202","36 / 1,072 (3.36%)","49 / 1,072 (4.57%)",21,,add to survival plot
MEIS1,Meis homeobox 1,19 / 986 (1.93%),"335 / 10,202","50 / 1,072 (4.66%)","15 / 1,072 (1.40%)",12,,add to survival plot
WWC3,WWC family member 3,19 / 986 (1.93%),"317 / 10,202","41 / 1,072 (3.82%)","24 / 1,072 (2.24%)",19,,add to survival plot
ARAP3,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",19 / 986 (1.93%),"305 / 10,202","47 / 1,072 (4.38%)","20 / 1,072 (1.87%)",19,,add to survival plot
AAK1,AP2 associated kinase 1,19 / 986 (1.93%),"217 / 10,202","46 / 1,072 (4.29%)","11 / 1,072 (1.03%)",20,,add to survival plot
NHS,Nance-Horan syndrome (congenital cataracts and dental anomalies),19 / 986 (1.93%),"373 / 10,202","39 / 1,072 (3.64%)","15 / 1,072 (1.40%)",21,,add to survival plot
PKD1L2,polycystic kidney disease 1-like 2 (gene/pseudogene),19 / 986 (1.93%),"449 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",20,,add to survival plot
ZP4,zona pellucida glycoprotein 4,19 / 986 (1.93%),"283 / 10,202","165 / 1,072 (15.39%)","28 / 1,072 (2.61%)",21,,add to survival plot
USP32,ubiquitin specific peptidase 32,19 / 986 (1.93%),"253 / 10,202","234 / 1,072 (21.83%)","11 / 1,072 (1.03%)",22,,add to survival plot
ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",19 / 986 (1.93%),"543 / 10,202","40 / 1,072 (3.73%)","114 / 1,072 (10.63%)",21,,add to survival plot
CDC42BPB,CDC42 binding protein kinase beta (DMPK-like),19 / 986 (1.93%),"320 / 10,202","61 / 1,072 (5.69%)","62 / 1,072 (5.78%)",20,,add to survival plot
NBPF14,"neuroblastoma breakpoint family, member 14",19 / 986 (1.93%),"131 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",10,,add to survival plot
BDP1,"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB",19 / 986 (1.93%),"384 / 10,202","12 / 1,072 (1.12%)","69 / 1,072 (6.44%)",21,,add to survival plot
C5,complement component 5,19 / 986 (1.93%),"269 / 10,202","46 / 1,072 (4.29%)","28 / 1,072 (2.61%)",22,,add to survival plot
CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",19 / 986 (1.93%),"516 / 10,202","146 / 1,072 (13.62%)","12 / 1,072 (1.12%)",22,,add to survival plot
DCHS1,dachsous cadherin-related 1,19 / 986 (1.93%),"521 / 10,202","29 / 1,072 (2.71%)","71 / 1,072 (6.62%)",26,,add to survival plot
MYH7B,"myosin, heavy chain 7B, cardiac muscle, beta",19 / 986 (1.93%),"357 / 10,202","54 / 1,072 (5.04%)","31 / 1,072 (2.89%)",24,,add to survival plot
BLM,"Bloom syndrome, RecQ helicase-like",19 / 986 (1.93%),"234 / 10,202","93 / 1,072 (8.68%)","15 / 1,072 (1.40%)",24,Cancer Gene Census,add to survival plot
UTP20,"UTP20, small subunit (SSU) processome component, homolog (yeast)",19 / 986 (1.93%),"408 / 10,202","27 / 1,072 (2.52%)","63 / 1,072 (5.88%)",19,,add to survival plot
MAP3K5,mitogen-activated protein kinase kinase kinase 5,19 / 986 (1.93%),"285 / 10,202","75 / 1,072 (7.00%)","55 / 1,072 (5.13%)",22,,add to survival plot
ABI3BP,"ABI family, member 3 (NESH) binding protein",19 / 986 (1.93%),"308 / 10,202","61 / 1,072 (5.69%)","24 / 1,072 (2.24%)",22,,add to survival plot
GCN1L1,GCN1 general control of amino-acid synthesis 1-like 1 (yeast),19 / 986 (1.93%),"448 / 10,202","38 / 1,072 (3.54%)","78 / 1,072 (7.28%)",23,,add to survival plot
FAM171A1,"family with sequence similarity 171, member A1",19 / 986 (1.93%),"290 / 10,202","80 / 1,072 (7.46%)","10 / 1,072 (0.93%)",21,,add to survival plot
RTL1,retrotransposon-like 1,19 / 986 (1.93%),"291 / 10,202","47 / 1,072 (4.38%)","59 / 1,072 (5.50%)",23,,add to survival plot
CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",19 / 986 (1.93%),"380 / 10,202","41 / 1,072 (3.82%)","27 / 1,072 (2.52%)",22,,add to survival plot
IFT122,intraflagellar transport 122,19 / 986 (1.93%),"252 / 10,202","44 / 1,072 (4.10%)","40 / 1,072 (3.73%)",21,,add to survival plot
LTBP1,latent transforming growth factor beta binding protein 1,19 / 986 (1.93%),"434 / 10,202","50 / 1,072 (4.66%)","21 / 1,072 (1.96%)",19,,add to survival plot
AIM1,absent in melanoma 1,19 / 986 (1.93%),"338 / 10,202","74 / 1,072 (6.90%)","63 / 1,072 (5.88%)",22,,add to survival plot
TNKS1BP1,"tankyrase 1 binding protein 1, 182kDa",19 / 986 (1.93%),"314 / 10,202","94 / 1,072 (8.77%)","43 / 1,072 (4.01%)",21,,add to survival plot
RIMS1,regulating synaptic membrane exocytosis 1,19 / 986 (1.93%),"566 / 10,202","70 / 1,072 (6.53%)","58 / 1,072 (5.41%)",24,,add to survival plot
KAT6A,K(lysine) acetyltransferase 6A,19 / 986 (1.93%),"390 / 10,202","164 / 1,072 (15.30%)","70 / 1,072 (6.53%)",19,Cancer Gene Census,add to survival plot
NLRC5,"NLR family, CARD domain containing 5",19 / 986 (1.93%),"386 / 10,202","26 / 1,072 (2.43%)","31 / 1,072 (2.89%)",21,,add to survival plot
SUCO,SUN domain containing ossification factor,19 / 986 (1.93%),"274 / 10,202","120 / 1,072 (11.19%)","34 / 1,072 (3.17%)",24,,add to survival plot
ZNF318,zinc finger protein 318,19 / 986 (1.93%),"379 / 10,202","75 / 1,072 (7.00%)","26 / 1,072 (2.43%)",20,,add to survival plot
COL11A1,"collagen, type XI, alpha 1",19 / 986 (1.93%),"831 / 10,202","34 / 1,072 (3.17%)","97 / 1,072 (9.05%)",20,,add to survival plot
COL18A1,"collagen, type XVIII, alpha 1",19 / 986 (1.93%),"309 / 10,202","71 / 1,072 (6.62%)","26 / 1,072 (2.43%)",19,,add to survival plot
PRRC2B,proline-rich coiled-coil 2B,19 / 986 (1.93%),"356 / 10,202","52 / 1,072 (4.85%)","35 / 1,072 (3.26%)",20,,add to survival plot
APC,adenomatous polyposis coli,19 / 986 (1.93%),"893 / 10,202","21 / 1,072 (1.96%)","44 / 1,072 (4.10%)",31,Cancer Gene Census,add to survival plot
STAB2,stabilin 2,19 / 986 (1.93%),"625 / 10,202","25 / 1,072 (2.33%)","70 / 1,072 (6.53%)",22,,add to survival plot
PTCH1,patched 1,19 / 986 (1.93%),"368 / 10,202","25 / 1,072 (2.33%)","34 / 1,072 (3.17%)",21,Cancer Gene Census,add to survival plot
BCL9,B-cell CLL/lymphoma 9,19 / 986 (1.93%),"331 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",22,Cancer Gene Census,add to survival plot
ABCA6,"ATP-binding cassette, sub-family A (ABC1), member 6",19 / 986 (1.93%),"330 / 10,202","236 / 1,072 (22.01%)","19 / 1,072 (1.77%)",22,,add to survival plot
SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,19 / 986 (1.93%),"297 / 10,202","39 / 1,072 (3.64%)","21 / 1,072 (1.96%)",22,,add to survival plot
ACTN2,"actinin, alpha 2",19 / 986 (1.93%),"340 / 10,202","169 / 1,072 (15.76%)","36 / 1,072 (3.36%)",22,,add to survival plot
KIF16B,kinesin family member 16B,19 / 986 (1.93%),"354 / 10,202","35 / 1,072 (3.26%)","32 / 1,072 (2.99%)",20,,add to survival plot
MYO9A,myosin IXA,19 / 986 (1.93%),"422 / 10,202","55 / 1,072 (5.13%)","28 / 1,072 (2.61%)",22,,add to survival plot
SPEF2,sperm flagellar 2,19 / 986 (1.93%),"507 / 10,202","63 / 1,072 (5.88%)","16 / 1,072 (1.49%)",24,,add to survival plot
SYCP2,synaptonemal complex protein 2,19 / 986 (1.93%),"339 / 10,202","132 / 1,072 (12.31%)","32 / 1,072 (2.99%)",20,,add to survival plot
CABIN1,calcineurin binding protein 1,19 / 986 (1.93%),"329 / 10,202","60 / 1,072 (5.60%)","25 / 1,072 (2.33%)",20,,add to survival plot
ESRRG,estrogen-related receptor gamma,19 / 986 (1.93%),"306 / 10,202","139 / 1,072 (12.97%)","30 / 1,072 (2.80%)",19,,add to survival plot
CRYBG3,beta-gamma crystallin domain containing 3,19 / 986 (1.93%),"232 / 10,202","56 / 1,072 (5.22%)","23 / 1,072 (2.15%)",21,,add to survival plot
TP53BP1,tumor protein p53 binding protein 1,19 / 986 (1.93%),"345 / 10,202","18 / 1,072 (1.68%)","93 / 1,072 (8.68%)",22,,add to survival plot
NBPF9,"neuroblastoma breakpoint family, member 9",18 / 986 (1.83%),"197 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",18,,add to survival plot
PKD1,polycystic kidney disease 1 (autosomal dominant),18 / 986 (1.83%),"453 / 10,202","88 / 1,072 (8.21%)","17 / 1,072 (1.59%)",19,,add to survival plot
NINL,ninein-like,18 / 986 (1.83%),"309 / 10,202","30 / 1,072 (2.80%)","38 / 1,072 (3.54%)",20,,add to survival plot
KANK1,KN motif and ankyrin repeat domains 1,18 / 986 (1.83%),"307 / 10,202","61 / 1,072 (5.69%)","33 / 1,072 (3.08%)",20,,add to survival plot
PHF12,PHD finger protein 12,18 / 986 (1.83%),"207 / 10,202","160 / 1,072 (14.93%)","28 / 1,072 (2.61%)",20,,add to survival plot
ZNF841,zinc finger protein 841,18 / 986 (1.83%),"195 / 10,202","81 / 1,072 (7.56%)","38 / 1,072 (3.54%)",19,,add to survival plot
EEA1,early endosome antigen 1,18 / 986 (1.83%),"225 / 10,202","50 / 1,072 (4.66%)","53 / 1,072 (4.94%)",20,,add to survival plot
PCDHGA3,"protocadherin gamma subfamily A, 3",18 / 986 (1.83%),"392 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",18,,add to survival plot
ROCK1,"Rho-associated, coiled-coil containing protein kinase 1",18 / 986 (1.83%),"329 / 10,202","41 / 1,072 (3.82%)","25 / 1,072 (2.33%)",19,,add to survival plot
WDR33,WD repeat domain 33,18 / 986 (1.83%),"373 / 10,202","18 / 1,072 (1.68%)","38 / 1,072 (3.54%)",22,,add to survival plot
NRXN2,neurexin 2,18 / 986 (1.83%),"378 / 10,202","102 / 1,072 (9.51%)","56 / 1,072 (5.22%)",18,,add to survival plot
GRIK2,"glutamate receptor, ionotropic, kainate 2",18 / 986 (1.83%),"424 / 10,202","59 / 1,072 (5.50%)","71 / 1,072 (6.62%)",17,,add to survival plot
SUPT5H,suppressor of Ty 5 homolog (S. cerevisiae),18 / 986 (1.83%),"272 / 10,202","68 / 1,072 (6.34%)","31 / 1,072 (2.89%)",19,,add to survival plot
CDH8,"cadherin 8, type 2",18 / 986 (1.83%),"510 / 10,202","24 / 1,072 (2.24%)","41 / 1,072 (3.82%)",18,,add to survival plot
PTPRC,"protein tyrosine phosphatase, receptor type, C",18 / 986 (1.83%),"455 / 10,202","136 / 1,072 (12.69%)","14 / 1,072 (1.31%)",19,Cancer Gene Census,add to survival plot
COL1A2,"collagen, type I, alpha 2",18 / 986 (1.83%),"476 / 10,202","37 / 1,072 (3.45%)","27 / 1,072 (2.52%)",20,,add to survival plot
KIF21A,kinesin family member 21A,18 / 986 (1.83%),"388 / 10,202","52 / 1,072 (4.85%)","28 / 1,072 (2.61%)",20,,add to survival plot
CCDC108,coiled-coil domain containing 108,18 / 986 (1.83%),"466 / 10,202","38 / 1,072 (3.54%)","51 / 1,072 (4.76%)",18,,add to survival plot
GRM1,"glutamate receptor, metabotropic 1",18 / 986 (1.83%),"516 / 10,202","61 / 1,072 (5.69%)","66 / 1,072 (6.16%)",19,,add to survival plot
SLITRK2,"SLIT and NTRK-like family, member 2",18 / 986 (1.83%),"414 / 10,202","55 / 1,072 (5.13%)","23 / 1,072 (2.15%)",21,,add to survival plot
ATXN2,ataxin 2,18 / 986 (1.83%),"246 / 10,202","31 / 1,072 (2.89%)","76 / 1,072 (7.09%)",20,,add to survival plot
MAP2K6,mitogen-activated protein kinase kinase 6,18 / 986 (1.83%),"179 / 10,202","236 / 1,072 (22.01%)","17 / 1,072 (1.59%)",18,,add to survival plot
RTN4,reticulon 4,18 / 986 (1.83%),"205 / 10,202","57 / 1,072 (5.32%)","7 / 1,072 (0.65%)",20,,add to survival plot
EEF1A1,eukaryotic translation elongation factor 1 alpha 1,18 / 986 (1.83%),"186 / 10,202","60 / 1,072 (5.60%)","53 / 1,072 (4.94%)",12,,add to survival plot
ZNF532,zinc finger protein 532,18 / 986 (1.83%),"264 / 10,202","32 / 1,072 (2.99%)","34 / 1,072 (3.17%)",18,,add to survival plot
PCDH10,protocadherin 10,18 / 986 (1.83%),"579 / 10,202","43 / 1,072 (4.01%)","29 / 1,072 (2.71%)",19,,add to survival plot
C10orf12,chromosome 10 open reading frame 12,18 / 986 (1.83%),"251 / 10,202","30 / 1,072 (2.80%)","73 / 1,072 (6.81%)",21,,add to survival plot
FHOD3,formin homology 2 domain containing 3,18 / 986 (1.83%),"357 / 10,202","34 / 1,072 (3.17%)","24 / 1,072 (2.24%)",19,,add to survival plot
CLCN5,"chloride channel, voltage-sensitive 5",18 / 986 (1.83%),"276 / 10,202","30 / 1,072 (2.80%)","10 / 1,072 (0.93%)",21,,add to survival plot
MYOM1,myomesin 1,18 / 986 (1.83%),"341 / 10,202","34 / 1,072 (3.17%)","22 / 1,072 (2.05%)",18,,add to survival plot
CNTN6,contactin 6,18 / 986 (1.83%),"457 / 10,202","94 / 1,072 (8.77%)","37 / 1,072 (3.45%)",21,,add to survival plot
TRIP11,thyroid hormone receptor interactor 11,18 / 986 (1.83%),"268 / 10,202","43 / 1,072 (4.01%)","70 / 1,072 (6.53%)",20,Cancer Gene Census,add to survival plot
SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",18 / 986 (1.83%),"404 / 10,202","69 / 1,072 (6.44%)","42 / 1,072 (3.92%)",19,,add to survival plot
HEG1,heart development protein with EGF-like domains 1,18 / 986 (1.83%),"234 / 10,202","38 / 1,072 (3.54%)","37 / 1,072 (3.45%)",20,,add to survival plot
MCM3AP,minichromosome maintenance complex component 3 associated protein,18 / 986 (1.83%),"367 / 10,202","80 / 1,072 (7.46%)","22 / 1,072 (2.05%)",21,,add to survival plot
ZNF687,zinc finger protein 687,18 / 986 (1.83%),"248 / 10,202","190 / 1,072 (17.72%)","19 / 1,072 (1.77%)",16,,add to survival plot
ATAD2,"ATPase family, AAA domain containing 2",18 / 986 (1.83%),"348 / 10,202","214 / 1,072 (19.96%)","23 / 1,072 (2.15%)",25,,add to survival plot
FLRT2,fibronectin leucine rich transmembrane protein 2,18 / 986 (1.83%),"529 / 10,202","23 / 1,072 (2.15%)","70 / 1,072 (6.53%)",17,,add to survival plot
LPA,"lipoprotein, Lp(a)",18 / 986 (1.83%),"497 / 10,202","55 / 1,072 (5.13%)","99 / 1,072 (9.24%)",18,,add to survival plot
MYO5A,"myosin VA (heavy chain 12, myoxin)",18 / 986 (1.83%),"319 / 10,202","40 / 1,072 (3.73%)","67 / 1,072 (6.25%)",19,Cancer Gene Census,add to survival plot
PCDHA10,protocadherin alpha 10,18 / 986 (1.83%),"497 / 10,202","47 / 1,072 (4.38%)","20 / 1,072 (1.87%)",22,,add to survival plot
COL19A1,"collagen, type XIX, alpha 1",18 / 986 (1.83%),"429 / 10,202","63 / 1,072 (5.88%)","58 / 1,072 (5.41%)",18,,add to survival plot
ASXL1,additional sex combs like transcriptional regulator 1,18 / 986 (1.83%),"344 / 10,202","51 / 1,072 (4.76%)","31 / 1,072 (2.89%)",23,Cancer Gene Census,add to survival plot
KMT2B,lysine (K)-specific methyltransferase 2B,18 / 986 (1.83%),"524 / 10,202","65 / 1,072 (6.06%)","18 / 1,072 (1.68%)",20,,add to survival plot
TNRC6C,trinucleotide repeat containing 6C,18 / 986 (1.83%),"265 / 10,202","209 / 1,072 (19.50%)","31 / 1,072 (2.89%)",20,,add to survival plot
ZEB2,zinc finger E-box binding homeobox 2,18 / 986 (1.83%),"449 / 10,202","18 / 1,072 (1.68%)","48 / 1,072 (4.48%)",19,,add to survival plot
NLGN3,neuroligin 3,18 / 986 (1.83%),"243 / 10,202","24 / 1,072 (2.24%)","20 / 1,072 (1.87%)",18,,add to survival plot
NSD1,nuclear receptor binding SET domain protein 1,18 / 986 (1.83%),"490 / 10,202","101 / 1,072 (9.42%)","26 / 1,072 (2.43%)",22,Cancer Gene Census,add to survival plot
ADNP,activity-dependent neuroprotector homeobox,18 / 986 (1.83%),"220 / 10,202","125 / 1,072 (11.66%)","23 / 1,072 (2.15%)",25,,add to survival plot
LRRIQ1,leucine-rich repeats and IQ motif containing 1,18 / 986 (1.83%),"486 / 10,202","49 / 1,072 (4.57%)","59 / 1,072 (5.50%)",19,,add to survival plot
CACHD1,cache domain containing 1,18 / 986 (1.83%),"255 / 10,202","53 / 1,072 (4.94%)","59 / 1,072 (5.50%)",18,,add to survival plot
STAB1,stabilin 1,18 / 986 (1.83%),"479 / 10,202","12 / 1,072 (1.12%)","141 / 1,072 (13.15%)",18,,add to survival plot
FGD5,"FYVE, RhoGEF and PH domain containing 5",18 / 986 (1.83%),"326 / 10,202","90 / 1,072 (8.40%)","23 / 1,072 (2.15%)",20,,add to survival plot
CAMSAP2,"calmodulin regulated spectrin-associated protein family, member 2",18 / 986 (1.83%),"315 / 10,202","147 / 1,072 (13.71%)","10 / 1,072 (0.93%)",23,,add to survival plot
SIGLEC1,"sialic acid binding Ig-like lectin 1, sialoadhesin",18 / 986 (1.83%),"426 / 10,202","46 / 1,072 (4.29%)","62 / 1,072 (5.78%)",18,,add to survival plot
VCPIP1,valosin containing protein (p97)/p47 complex interacting protein 1,18 / 986 (1.83%),"230 / 10,202","113 / 1,072 (10.54%)","46 / 1,072 (4.29%)",20,,add to survival plot
MUC6,"mucin 6, oligomeric mucus/gel-forming",18 / 986 (1.83%),"420 / 10,202","33 / 1,072 (3.08%)","88 / 1,072 (8.21%)",23,,add to survival plot
ANKS1B,ankyrin repeat and sterile alpha motif domain containing 1B,18 / 986 (1.83%),"386 / 10,202","48 / 1,072 (4.48%)","90 / 1,072 (8.40%)",18,,add to survival plot
DOCK2,dedicator of cytokinesis 2,18 / 986 (1.83%),"608 / 10,202","63 / 1,072 (5.88%)","30 / 1,072 (2.80%)",19,,add to survival plot
PPP1R12A,"protein phosphatase 1, regulatory subunit 12A",18 / 986 (1.83%),"200 / 10,202","54 / 1,072 (5.04%)","44 / 1,072 (4.10%)",18,,add to survival plot
PMFBP1,polyamine modulated factor 1 binding protein 1,18 / 986 (1.83%),"293 / 10,202","35 / 1,072 (3.26%)","47 / 1,072 (4.38%)",18,,add to survival plot
SRGAP1,SLIT-ROBO Rho GTPase activating protein 1,18 / 986 (1.83%),"271 / 10,202","67 / 1,072 (6.25%)","22 / 1,072 (2.05%)",21,,add to survival plot
NUP98,nucleoporin 98kDa,18 / 986 (1.83%),"307 / 10,202","38 / 1,072 (3.54%)","76 / 1,072 (7.09%)",20,Cancer Gene Census,add to survival plot
DMBT1,deleted in malignant brain tumors 1,18 / 986 (1.83%),"525 / 10,202","48 / 1,072 (4.48%)","72 / 1,072 (6.72%)",18,,add to survival plot
MYH15,"myosin, heavy chain 15",18 / 986 (1.83%),"481 / 10,202","48 / 1,072 (4.48%)","20 / 1,072 (1.87%)",22,,add to survival plot
ANKRD36C,ankyrin repeat domain 36C,18 / 986 (1.83%),"203 / 10,202","52 / 1,072 (4.85%)","20 / 1,072 (1.87%)",19,,add to survival plot
ADGRF5,adhesion G protein-coupled receptor F5,18 / 986 (1.83%),"330 / 10,202","62 / 1,072 (5.78%)","26 / 1,072 (2.43%)",20,,add to survival plot
HIST1H3B,"histone cluster 1, H3b",18 / 986 (1.83%),"120 / 10,202","88 / 1,072 (8.21%)","30 / 1,072 (2.80%)",18,,add to survival plot
NBPF11,"neuroblastoma breakpoint family, member 11",18 / 986 (1.83%),"250 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",16,,add to survival plot
DOCK7,dedicator of cytokinesis 7,18 / 986 (1.83%),"321 / 10,202","67 / 1,072 (6.25%)","55 / 1,072 (5.13%)",21,,add to survival plot
SETDB1,"SET domain, bifurcated 1",18 / 986 (1.83%),"265 / 10,202","197 / 1,072 (18.38%)","19 / 1,072 (1.77%)",19,,add to survival plot
PCDHB11,protocadherin beta 11,18 / 986 (1.83%),"360 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",18,,add to survival plot
KIAA2026,KIAA2026,18 / 986 (1.83%),"333 / 10,202","58 / 1,072 (5.41%)","34 / 1,072 (3.17%)",21,,add to survival plot
CASP8AP2,caspase 8 associated protein 2,18 / 986 (1.83%),"288 / 10,202","33 / 1,072 (3.08%)","78 / 1,072 (7.28%)",19,,add to survival plot
TSHZ1,teashirt zinc finger homeobox 1,18 / 986 (1.83%),"315 / 10,202","39 / 1,072 (3.64%)","49 / 1,072 (4.57%)",16,,add to survival plot
TRIP12,thyroid hormone receptor interactor 12,18 / 986 (1.83%),"378 / 10,202","25 / 1,072 (2.33%)","74 / 1,072 (6.90%)",23,,add to survival plot
ITGA10,"integrin, alpha 10",18 / 986 (1.83%),"308 / 10,202","185 / 1,072 (17.26%)","41 / 1,072 (3.82%)",17,,add to survival plot
TIAM2,T-cell lymphoma invasion and metastasis 2,18 / 986 (1.83%),"400 / 10,202","57 / 1,072 (5.32%)","85 / 1,072 (7.93%)",20,,add to survival plot
PZP,pregnancy-zone protein,18 / 986 (1.83%),"403 / 10,202","52 / 1,072 (4.85%)","49 / 1,072 (4.57%)",19,,add to survival plot
KCNH7,"potassium channel, voltage gated eag related subfamily H, member 7",18 / 986 (1.83%),"446 / 10,202","32 / 1,072 (2.99%)","25 / 1,072 (2.33%)",18,,add to survival plot
SALL1,spalt-like transcription factor 1,18 / 986 (1.83%),"549 / 10,202","43 / 1,072 (4.01%)","36 / 1,072 (3.36%)",21,,add to survival plot
ABCA10,"ATP-binding cassette, sub-family A (ABC1), member 10",18 / 986 (1.83%),"343 / 10,202","238 / 1,072 (22.20%)","18 / 1,072 (1.68%)",21,,add to survival plot
CNTN1,contactin 1,18 / 986 (1.83%),"389 / 10,202","54 / 1,072 (5.04%)","27 / 1,072 (2.52%)",17,,add to survival plot
GUCY2C,guanylate cyclase 2C,18 / 986 (1.83%),"332 / 10,202","30 / 1,072 (2.80%)","62 / 1,072 (5.78%)",18,,add to survival plot
RBMXL3,"RNA binding motif protein, X-linked-like 3",18 / 986 (1.83%),"190 / 10,202","35 / 1,072 (3.26%)","23 / 1,072 (2.15%)",18,,add to survival plot
FOCAD,focadhesin,18 / 986 (1.83%),"278 / 10,202","38 / 1,072 (3.54%)","40 / 1,072 (3.73%)",23,,add to survival plot
ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13",18 / 986 (1.83%),"275 / 10,202","49 / 1,072 (4.57%)","41 / 1,072 (3.82%)",18,,add to survival plot
PCDHGA7,"protocadherin gamma subfamily A, 7",18 / 986 (1.83%),"284 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",18,,add to survival plot
DENND5B,DENN/MADD domain containing 5B,18 / 986 (1.83%),"248 / 10,202","66 / 1,072 (6.16%)","14 / 1,072 (1.31%)",21,,add to survival plot
GLI3,GLI family zinc finger 3,18 / 986 (1.83%),"533 / 10,202","40 / 1,072 (3.73%)","19 / 1,072 (1.77%)",20,,add to survival plot
GPR179,G protein-coupled receptor 179,18 / 986 (1.83%),"397 / 10,202","99 / 1,072 (9.24%)","69 / 1,072 (6.44%)",21,,add to survival plot
MICAL3,"microtubule associated monooxygenase, calponin and LIM domain containing 3",18 / 986 (1.83%),"372 / 10,202","62 / 1,072 (5.78%)","43 / 1,072 (4.01%)",20,,add to survival plot
ATP10A,"ATPase, class V, type 10A",18 / 986 (1.83%),"497 / 10,202","47 / 1,072 (4.38%)","95 / 1,072 (8.86%)",17,,add to survival plot
NUP160,nucleoporin 160kDa,18 / 986 (1.83%),"245 / 10,202","68 / 1,072 (6.34%)","21 / 1,072 (1.96%)",24,,add to survival plot
LRP12,low density lipoprotein receptor-related protein 12,18 / 986 (1.83%),"327 / 10,202","197 / 1,072 (18.38%)","11 / 1,072 (1.03%)",18,,add to survival plot
GSE1,Gse1 coiled-coil protein,18 / 986 (1.83%),"243 / 10,202","39 / 1,072 (3.64%)","63 / 1,072 (5.88%)",18,,add to survival plot
ATP1A4,"ATPase, Na+/K+ transporting, alpha 4 polypeptide",18 / 986 (1.83%),"321 / 10,202","152 / 1,072 (14.18%)","23 / 1,072 (2.15%)",21,,add to survival plot
SORBS2,sorbin and SH3 domain containing 2,18 / 986 (1.83%),"327 / 10,202","56 / 1,072 (5.22%)","71 / 1,072 (6.62%)",19,,add to survival plot
PRKCB,"protein kinase C, beta",18 / 986 (1.83%),"351 / 10,202","44 / 1,072 (4.10%)","14 / 1,072 (1.31%)",19,,add to survival plot
DENND4B,DENN/MADD domain containing 4B,18 / 986 (1.83%),"280 / 10,202","165 / 1,072 (15.39%)","25 / 1,072 (2.33%)",19,,add to survival plot
TTC21A,tetratricopeptide repeat domain 21A,18 / 986 (1.83%),"258 / 10,202","32 / 1,072 (2.99%)","81 / 1,072 (7.56%)",20,,add to survival plot
KIF21B,kinesin family member 21B,18 / 986 (1.83%),"472 / 10,202","145 / 1,072 (13.53%)","11 / 1,072 (1.03%)",21,,add to survival plot
GOLGA3,golgin A3,18 / 986 (1.83%),"324 / 10,202","39 / 1,072 (3.64%)","83 / 1,072 (7.74%)",21,,add to survival plot
DGKG,"diacylglycerol kinase, gamma 90kDa",18 / 986 (1.83%),"283 / 10,202","130 / 1,072 (12.13%)","19 / 1,072 (1.77%)",18,,add to survival plot
FAM208B,"family with sequence similarity 208, member B",18 / 986 (1.83%),"313 / 10,202","122 / 1,072 (11.38%)","10 / 1,072 (0.93%)",23,,add to survival plot
MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",18 / 986 (1.83%),"470 / 10,202","44 / 1,072 (4.10%)","28 / 1,072 (2.61%)",18,,add to survival plot
FTSJ3,FtsJ homolog 3 (E. coli),18 / 986 (1.83%),"186 / 10,202","233 / 1,072 (21.74%)","14 / 1,072 (1.31%)",20,,add to survival plot
NUP205,nucleoporin 205kDa,18 / 986 (1.83%),"371 / 10,202","60 / 1,072 (5.60%)","38 / 1,072 (3.54%)",21,,add to survival plot
ERCC6,excision repair cross-complementation group 6,18 / 986 (1.83%),"296 / 10,202","44 / 1,072 (4.10%)","35 / 1,072 (3.26%)",24,,add to survival plot
CD163L1,CD163 molecule-like 1,18 / 986 (1.83%),"440 / 10,202","64 / 1,072 (5.97%)","46 / 1,072 (4.29%)",19,,add to survival plot
PRRC2C,proline-rich coiled-coil 2C,18 / 986 (1.83%),"373 / 10,202","118 / 1,072 (11.01%)","35 / 1,072 (3.26%)",20,,add to survival plot
IREB2,iron-responsive element binding protein 2,18 / 986 (1.83%),"197 / 10,202","58 / 1,072 (5.41%)","22 / 1,072 (2.05%)",20,,add to survival plot
IPO8,importin 8,18 / 986 (1.83%),"216 / 10,202","56 / 1,072 (5.22%)","19 / 1,072 (1.77%)",21,,add to survival plot
CELF2,"CUGBP, Elav-like family member 2",18 / 986 (1.83%),"245 / 10,202","105 / 1,072 (9.79%)","13 / 1,072 (1.21%)",14,,add to survival plot
NLRP2,"NLR family, pyrin domain containing 2",18 / 986 (1.83%),"375 / 10,202","79 / 1,072 (7.37%)","35 / 1,072 (3.26%)",19,,add to survival plot
ASCC3,activating signal cointegrator 1 complex subunit 3,17 / 986 (1.72%),"350 / 10,202","59 / 1,072 (5.50%)","74 / 1,072 (6.90%)",19,,add to survival plot
TNRC18,trinucleotide repeat containing 18,17 / 986 (1.72%),"370 / 10,202","54 / 1,072 (5.04%)","45 / 1,072 (4.20%)",20,,add to survival plot
DAAM2,dishevelled associated activator of morphogenesis 2,17 / 986 (1.72%),"276 / 10,202","59 / 1,072 (5.50%)","27 / 1,072 (2.52%)",18,,add to survival plot
PARP1,poly (ADP-ribose) polymerase 1,17 / 986 (1.72%),"209 / 10,202","150 / 1,072 (13.99%)","24 / 1,072 (2.24%)",18,,add to survival plot
RGAG1,retrotransposon gag domain containing 1,17 / 986 (1.72%),"340 / 10,202","26 / 1,072 (2.43%)","27 / 1,072 (2.52%)",19,,add to survival plot
MROH1,maestro heat-like repeat family member 1,17 / 986 (1.72%),"288 / 10,202","168 / 1,072 (15.67%)","80 / 1,072 (7.46%)",21,,add to survival plot
FGD6,"FYVE, RhoGEF and PH domain containing 6",17 / 986 (1.72%),"270 / 10,202","42 / 1,072 (3.92%)","56 / 1,072 (5.22%)",20,,add to survival plot
ANO2,"anoctamin 2, calcium activated chloride channel",17 / 986 (1.72%),"325 / 10,202","68 / 1,072 (6.34%)","49 / 1,072 (4.57%)",17,,add to survival plot
CEP295,centrosomal protein 295kDa,17 / 986 (1.72%),"258 / 10,202","62 / 1,072 (5.78%)","93 / 1,072 (8.68%)",18,,add to survival plot
NELL1,NEL-like 1 (chicken),17 / 986 (1.72%),"389 / 10,202","66 / 1,072 (6.16%)","35 / 1,072 (3.26%)",19,,add to survival plot
SOX6,SRY (sex determining region Y)-box 6,17 / 986 (1.72%),"276 / 10,202","48 / 1,072 (4.48%)","43 / 1,072 (4.01%)",18,,add to survival plot
PCDHGA1,"protocadherin gamma subfamily A, 1",17 / 986 (1.72%),"352 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",21,,add to survival plot
MECOM,MDS1 and EVI1 complex locus,17 / 986 (1.72%),"415 / 10,202","146 / 1,072 (13.62%)","13 / 1,072 (1.21%)",19,Cancer Gene Census,add to survival plot
GREB1,growth regulation by estrogen in breast cancer 1,17 / 986 (1.72%),"467 / 10,202","44 / 1,072 (4.10%)","50 / 1,072 (4.66%)",18,,add to survival plot
ARHGAP24,Rho GTPase activating protein 24,17 / 986 (1.72%),"203 / 10,202","46 / 1,072 (4.29%)","25 / 1,072 (2.33%)",18,,add to survival plot
UBA6,ubiquitin-like modifier activating enzyme 6,17 / 986 (1.72%),"250 / 10,202","73 / 1,072 (6.81%)","12 / 1,072 (1.12%)",17,,add to survival plot
NUMA1,nuclear mitotic apparatus protein 1,17 / 986 (1.72%),"334 / 10,202","162 / 1,072 (15.11%)","48 / 1,072 (4.48%)",22,Cancer Gene Census,add to survival plot
FRMPD1,FERM and PDZ domain containing 1,17 / 986 (1.72%),"386 / 10,202","49 / 1,072 (4.57%)","27 / 1,072 (2.52%)",20,,add to survival plot
NLRP1,"NLR family, pyrin domain containing 1",17 / 986 (1.72%),"358 / 10,202","29 / 1,072 (2.71%)","33 / 1,072 (3.08%)",18,,add to survival plot
TRANK1,tetratricopeptide repeat and ankyrin repeat containing 1,17 / 986 (1.72%),"469 / 10,202","38 / 1,072 (3.54%)","70 / 1,072 (6.53%)",20,,add to survival plot
ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",17 / 986 (1.72%),"338 / 10,202","36 / 1,072 (3.36%)","27 / 1,072 (2.52%)",20,,add to survival plot
ATP2B2,"ATPase, Ca++ transporting, plasma membrane 2",17 / 986 (1.72%),"440 / 10,202","96 / 1,072 (8.96%)","26 / 1,072 (2.43%)",20,,add to survival plot
PCDH9,protocadherin 9,17 / 986 (1.72%),"492 / 10,202","40 / 1,072 (3.73%)","48 / 1,072 (4.48%)",18,,add to survival plot
UBC,ubiquitin C,17 / 986 (1.72%),"172 / 10,202","39 / 1,072 (3.64%)","85 / 1,072 (7.93%)",18,,add to survival plot
XPO1,exportin 1,17 / 986 (1.72%),"211 / 10,202","62 / 1,072 (5.78%)","9 / 1,072 (0.84%)",21,Cancer Gene Census,add to survival plot
AGBL1,ATP/GTP binding protein-like 1,17 / 986 (1.72%),"360 / 10,202","90 / 1,072 (8.40%)","30 / 1,072 (2.80%)",17,,add to survival plot
MAST1,microtubule associated serine/threonine kinase 1,17 / 986 (1.72%),"301 / 10,202","56 / 1,072 (5.22%)","34 / 1,072 (3.17%)",19,,add to survival plot
CLTC,"clathrin, heavy chain (Hc)",17 / 986 (1.72%),"273 / 10,202","229 / 1,072 (21.36%)","12 / 1,072 (1.12%)",24,Cancer Gene Census,add to survival plot
THOC2,THO complex 2,17 / 986 (1.72%),"359 / 10,202","34 / 1,072 (3.17%)","20 / 1,072 (1.87%)",18,,add to survival plot
MAPKBP1,mitogen-activated protein kinase binding protein 1,17 / 986 (1.72%),"294 / 10,202","21 / 1,072 (1.96%)","99 / 1,072 (9.24%)",19,,add to survival plot
MAP3K13,mitogen-activated protein kinase kinase kinase 13,17 / 986 (1.72%),"242 / 10,202","130 / 1,072 (12.13%)","22 / 1,072 (2.05%)",18,Cancer Gene Census,add to survival plot
PI4KA,"phosphatidylinositol 4-kinase, catalytic, alpha",17 / 986 (1.72%),"356 / 10,202","70 / 1,072 (6.53%)","39 / 1,072 (3.64%)",21,,add to survival plot
COL5A2,"collagen, type V, alpha 2",17 / 986 (1.72%),"435 / 10,202","56 / 1,072 (5.22%)","21 / 1,072 (1.96%)",17,,add to survival plot
LILRB5,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5",17 / 986 (1.72%),"436 / 10,202","83 / 1,072 (7.74%)","33 / 1,072 (3.08%)",17,,add to survival plot
INADL,InaD-like (Drosophila),17 / 986 (1.72%),"378 / 10,202","70 / 1,072 (6.53%)","54 / 1,072 (5.04%)",19,,add to survival plot
ZNF648,zinc finger protein 648,17 / 986 (1.72%),"226 / 10,202","105 / 1,072 (9.79%)","26 / 1,072 (2.43%)",17,,add to survival plot
HTATSF1,HIV-1 Tat specific factor 1,17 / 986 (1.72%),"215 / 10,202","50 / 1,072 (4.66%)","19 / 1,072 (1.77%)",20,,add to survival plot
ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",17 / 986 (1.72%),"214 / 10,202","25 / 1,072 (2.33%)","34 / 1,072 (3.17%)",17,,add to survival plot
NLRP3,"NLR family, pyrin domain containing 3",17 / 986 (1.72%),"525 / 10,202","177 / 1,072 (16.51%)","33 / 1,072 (3.08%)",19,,add to survival plot
RP11-231C14.4,RP11-231C14.4,17 / 986 (1.72%),"77 / 10,202","62 / 1,072 (5.78%)","8 / 1,072 (0.75%)",9,,add to survival plot
TMPRSS15,"transmembrane protease, serine 15",17 / 986 (1.72%),"384 / 10,202","35 / 1,072 (3.26%)","61 / 1,072 (5.69%)",17,,add to survival plot
TLR7,toll-like receptor 7,17 / 986 (1.72%),"269 / 10,202","38 / 1,072 (3.54%)","22 / 1,072 (2.05%)",18,,add to survival plot
LTBP2,latent transforming growth factor beta binding protein 2,17 / 986 (1.72%),"365 / 10,202","17 / 1,072 (1.59%)","84 / 1,072 (7.84%)",18,,add to survival plot
ADCY9,adenylate cyclase 9,17 / 986 (1.72%),"312 / 10,202","75 / 1,072 (7.00%)","19 / 1,072 (1.77%)",20,,add to survival plot
GRIPAP1,GRIP1 associated protein 1,17 / 986 (1.72%),"182 / 10,202","30 / 1,072 (2.80%)","10 / 1,072 (0.93%)",19,,add to survival plot
C11orf30,chromosome 11 open reading frame 30,17 / 986 (1.72%),"256 / 10,202","171 / 1,072 (15.95%)","37 / 1,072 (3.45%)",23,,add to survival plot
VWA3A,von Willebrand factor A domain containing 3A,17 / 986 (1.72%),"245 / 10,202","39 / 1,072 (3.64%)","15 / 1,072 (1.40%)",18,,add to survival plot
TCF4,transcription factor 4,17 / 986 (1.72%),"305 / 10,202","30 / 1,072 (2.80%)","32 / 1,072 (2.99%)",17,,add to survival plot
KIAA1217,KIAA1217,17 / 986 (1.72%),"496 / 10,202","44 / 1,072 (4.10%)","26 / 1,072 (2.43%)",23,,add to survival plot
FAM21A,"family with sequence similarity 21, member A",17 / 986 (1.72%),"256 / 10,202","42 / 1,072 (3.92%)","36 / 1,072 (3.36%)",17,,add to survival plot
RBM25,RNA binding motif protein 25,17 / 986 (1.72%),"252 / 10,202","16 / 1,072 (1.49%)","78 / 1,072 (7.28%)",16,,add to survival plot
FRYL,FRY-like,17 / 986 (1.72%),"439 / 10,202","67 / 1,072 (6.25%)","11 / 1,072 (1.03%)",19,,add to survival plot
FLAD1,flavin adenine dinucleotide synthetase 1,17 / 986 (1.72%),"168 / 10,202","172 / 1,072 (16.04%)","22 / 1,072 (2.05%)",17,,add to survival plot
DOCK5,dedicator of cytokinesis 5,17 / 986 (1.72%),"343 / 10,202","14 / 1,072 (1.31%)","98 / 1,072 (9.14%)",18,,add to survival plot
KIAA0319,KIAA0319,17 / 986 (1.72%),"305 / 10,202","89 / 1,072 (8.30%)","31 / 1,072 (2.89%)",18,,add to survival plot
BAZ2A,"bromodomain adjacent to zinc finger domain, 2A",17 / 986 (1.72%),"284 / 10,202","37 / 1,072 (3.45%)","39 / 1,072 (3.64%)",20,,add to survival plot
IGF2BP2,insulin-like growth factor 2 mRNA binding protein 2,17 / 986 (1.72%),"263 / 10,202","127 / 1,072 (11.85%)","20 / 1,072 (1.87%)",16,,add to survival plot
ESR1,estrogen receptor 1,17 / 986 (1.72%),"223 / 10,202","106 / 1,072 (9.89%)","78 / 1,072 (7.28%)",16,Cancer Gene Census,add to survival plot
PLEKHA6,"pleckstrin homology domain containing, family A member 6",17 / 986 (1.72%),"314 / 10,202","171 / 1,072 (15.95%)","7 / 1,072 (0.65%)",23,,add to survival plot
PHF3,PHD finger protein 3,17 / 986 (1.72%),"367 / 10,202","79 / 1,072 (7.37%)","43 / 1,072 (4.01%)",20,,add to survival plot
ZMYM4,"zinc finger, MYM-type 4",17 / 986 (1.72%),"265 / 10,202","45 / 1,072 (4.20%)","74 / 1,072 (6.90%)",17,,add to survival plot
MLH3,mutL homolog 3,17 / 986 (1.72%),"238 / 10,202","15 / 1,072 (1.40%)","82 / 1,072 (7.65%)",18,,add to survival plot
NRIP1,nuclear receptor interacting protein 1,17 / 986 (1.72%),"287 / 10,202","47 / 1,072 (4.38%)","64 / 1,072 (5.97%)",18,,add to survival plot
RICTOR,"RPTOR independent companion of MTOR, complex 2",17 / 986 (1.72%),"322 / 10,202","61 / 1,072 (5.69%)","14 / 1,072 (1.31%)",17,,add to survival plot
CEP290,centrosomal protein 290kDa,17 / 986 (1.72%),"334 / 10,202","46 / 1,072 (4.29%)","52 / 1,072 (4.85%)",20,,add to survival plot
MYO18A,myosin XVIIIA,17 / 986 (1.72%),"318 / 10,202","152 / 1,072 (14.18%)","27 / 1,072 (2.52%)",21,,add to survival plot
ESYT1,extended synaptotagmin-like protein 1,17 / 986 (1.72%),"204 / 10,202","40 / 1,072 (3.73%)","41 / 1,072 (3.82%)",16,,add to survival plot
KIAA0100,KIAA0100,17 / 986 (1.72%),"372 / 10,202","154 / 1,072 (14.37%)","30 / 1,072 (2.80%)",19,,add to survival plot
APOBR,apolipoprotein B receptor,17 / 986 (1.72%),"199 / 10,202","56 / 1,072 (5.22%)","6 / 1,072 (0.56%)",22,,add to survival plot
ATP13A4,ATPase type 13A4,17 / 986 (1.72%),"328 / 10,202","138 / 1,072 (12.87%)","26 / 1,072 (2.43%)",17,,add to survival plot
ARHGAP5,Rho GTPase activating protein 5,17 / 986 (1.72%),"308 / 10,202","91 / 1,072 (8.49%)","17 / 1,072 (1.59%)",21,,add to survival plot
NRP2,neuropilin 2,17 / 986 (1.72%),"309 / 10,202","52 / 1,072 (4.85%)","38 / 1,072 (3.54%)",18,,add to survival plot
ZNF592,zinc finger protein 592,17 / 986 (1.72%),"235 / 10,202","86 / 1,072 (8.02%)","18 / 1,072 (1.68%)",20,,add to survival plot
TRDN,triadin,17 / 986 (1.72%),"220 / 10,202","59 / 1,072 (5.50%)","48 / 1,072 (4.48%)",19,,add to survival plot
RGS7,regulator of G-protein signaling 7,17 / 986 (1.72%),"307 / 10,202","165 / 1,072 (15.39%)","44 / 1,072 (4.10%)",18,,add to survival plot
ZNF407,zinc finger protein 407,17 / 986 (1.72%),"394 / 10,202","46 / 1,072 (4.29%)","50 / 1,072 (4.66%)",17,,add to survival plot
RALGAPA1,"Ral GTPase activating protein, alpha subunit 1 (catalytic)",17 / 986 (1.72%),"298 / 10,202","97 / 1,072 (9.05%)","17 / 1,072 (1.59%)",21,,add to survival plot
DOCK3,dedicator of cytokinesis 3,17 / 986 (1.72%),"506 / 10,202","12 / 1,072 (1.12%)","149 / 1,072 (13.90%)",19,,add to survival plot
CDH26,cadherin 26,17 / 986 (1.72%),"271 / 10,202","130 / 1,072 (12.13%)","32 / 1,072 (2.99%)",19,,add to survival plot
SMARCA1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",17 / 986 (1.72%),"253 / 10,202","37 / 1,072 (3.45%)","21 / 1,072 (1.96%)",18,,add to survival plot
FCRL3,Fc receptor-like 3,17 / 986 (1.72%),"398 / 10,202","146 / 1,072 (13.62%)","28 / 1,072 (2.61%)",22,,add to survival plot
UBR2,ubiquitin protein ligase E3 component n-recognin 2,17 / 986 (1.72%),"263 / 10,202","74 / 1,072 (6.90%)","24 / 1,072 (2.24%)",18,,add to survival plot
SHPRH,"SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase",17 / 986 (1.72%),"340 / 10,202","62 / 1,072 (5.78%)","65 / 1,072 (6.06%)",20,,add to survival plot
ADGRL4,adhesion G protein-coupled receptor L4,17 / 986 (1.72%),"341 / 10,202","37 / 1,072 (3.45%)","66 / 1,072 (6.16%)",18,,add to survival plot
DPP10,dipeptidyl-peptidase 10 (non-functional),17 / 986 (1.72%),"439 / 10,202","41 / 1,072 (3.82%)","35 / 1,072 (3.26%)",19,,add to survival plot
ARHGAP29,Rho GTPase activating protein 29,17 / 986 (1.72%),"298 / 10,202","39 / 1,072 (3.64%)","101 / 1,072 (9.42%)",20,,add to survival plot
ZNF608,zinc finger protein 608,17 / 986 (1.72%),"277 / 10,202","29 / 1,072 (2.71%)","41 / 1,072 (3.82%)",20,,add to survival plot
CDK12,cyclin-dependent kinase 12,17 / 986 (1.72%),"331 / 10,202","159 / 1,072 (14.83%)","48 / 1,072 (4.48%)",20,Cancer Gene Census,add to survival plot
CAPRIN2,caprin family member 2,17 / 986 (1.72%),"237 / 10,202","59 / 1,072 (5.50%)","17 / 1,072 (1.59%)",17,,add to survival plot
NCOA3,nuclear receptor coactivator 3,17 / 986 (1.72%),"333 / 10,202","86 / 1,072 (8.02%)","39 / 1,072 (3.64%)",18,,add to survival plot
SPG11,spastic paraplegia 11 (autosomal recessive),17 / 986 (1.72%),"350 / 10,202","26 / 1,072 (2.43%)","90 / 1,072 (8.40%)",17,,add to survival plot
PCDHB12,protocadherin beta 12,17 / 986 (1.72%),"422 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",18,,add to survival plot
EPHA7,EPH receptor A7,17 / 986 (1.72%),"431 / 10,202","40 / 1,072 (3.73%)","81 / 1,072 (7.56%)",17,,add to survival plot
USP15,ubiquitin specific peptidase 15,17 / 986 (1.72%),"225 / 10,202","58 / 1,072 (5.41%)","29 / 1,072 (2.71%)",17,,add to survival plot
WDR17,WD repeat domain 17,17 / 986 (1.72%),"354 / 10,202","43 / 1,072 (4.01%)","60 / 1,072 (5.60%)",18,,add to survival plot
ZNF658,zinc finger protein 658,17 / 986 (1.72%),"278 / 10,202","60 / 1,072 (5.60%)","44 / 1,072 (4.10%)",16,,add to survival plot
MEIS2,Meis homeobox 2,17 / 986 (1.72%),"278 / 10,202","24 / 1,072 (2.24%)","94 / 1,072 (8.77%)",18,,add to survival plot
TEK,"TEK tyrosine kinase, endothelial",17 / 986 (1.72%),"290 / 10,202","32 / 1,072 (2.99%)","31 / 1,072 (2.89%)",20,,add to survival plot
SPTAN1,"spectrin, alpha, non-erythrocytic 1",17 / 986 (1.72%),"446 / 10,202","55 / 1,072 (5.13%)","33 / 1,072 (3.08%)",20,,add to survival plot
PLD5,"phospholipase D family, member 5",17 / 986 (1.72%),"263 / 10,202","164 / 1,072 (15.30%)","38 / 1,072 (3.54%)",17,,add to survival plot
LRRC16B,leucine rich repeat containing 16B,17 / 986 (1.72%),"311 / 10,202","77 / 1,072 (7.18%)","29 / 1,072 (2.71%)",18,,add to survival plot
BRIP1,BRCA1 interacting protein C-terminal helicase 1,17 / 986 (1.72%),"257 / 10,202","234 / 1,072 (21.83%)","11 / 1,072 (1.03%)",18,Cancer Gene Census,add to survival plot
DCDC1,doublecortin domain containing 1,17 / 986 (1.72%),"532 / 10,202","71 / 1,072 (6.62%)","15 / 1,072 (1.40%)",18,,add to survival plot
PRX,periaxin,17 / 986 (1.72%),"293 / 10,202","52 / 1,072 (4.85%)","35 / 1,072 (3.26%)",19,,add to survival plot
INSRR,insulin receptor-related receptor,17 / 986 (1.72%),"375 / 10,202","146 / 1,072 (13.62%)","25 / 1,072 (2.33%)",17,,add to survival plot
ARFGEF3,ARFGEF family member 3,17 / 986 (1.72%),"365 / 10,202","78 / 1,072 (7.28%)","56 / 1,072 (5.22%)",18,,add to survival plot
RALGAPB,"Ral GTPase activating protein, beta subunit (non-catalytic)",17 / 986 (1.72%),"308 / 10,202","56 / 1,072 (5.22%)","31 / 1,072 (2.89%)",23,,add to survival plot
TRPC7,"transient receptor potential cation channel, subfamily C, member 7",17 / 986 (1.72%),"334 / 10,202","35 / 1,072 (3.26%)","30 / 1,072 (2.80%)",19,,add to survival plot
ITIH6,"inter-alpha-trypsin inhibitor heavy chain family, member 6",17 / 986 (1.72%),"351 / 10,202","48 / 1,072 (4.48%)","5 / 1,072 (0.47%)",18,,add to survival plot
ZGRF1,"zinc finger, GRF-type containing 1",17 / 986 (1.72%),"303 / 10,202","36 / 1,072 (3.36%)","39 / 1,072 (3.64%)",23,,add to survival plot
WHSC1L1,Wolf-Hirschhorn syndrome candidate 1-like 1,17 / 986 (1.72%),"298 / 10,202","193 / 1,072 (18.00%)","51 / 1,072 (4.76%)",20,Cancer Gene Census,add to survival plot
PCDHB16,protocadherin beta 16,17 / 986 (1.72%),"377 / 10,202","48 / 1,072 (4.48%)","22 / 1,072 (2.05%)",20,,add to survival plot
GRIN3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",17 / 986 (1.72%),"397 / 10,202","24 / 1,072 (2.24%)","44 / 1,072 (4.10%)",17,,add to survival plot
ALDH1L1,"aldehyde dehydrogenase 1 family, member L1",17 / 986 (1.72%),"291 / 10,202","32 / 1,072 (2.99%)","37 / 1,072 (3.45%)",18,,add to survival plot
CPSF1,"cleavage and polyadenylation specific factor 1, 160kDa",17 / 986 (1.72%),"245 / 10,202","165 / 1,072 (15.39%)","80 / 1,072 (7.46%)",17,,add to survival plot
ZNF91,zinc finger protein 91,17 / 986 (1.72%),"342 / 10,202","54 / 1,072 (5.04%)","23 / 1,072 (2.15%)",20,,add to survival plot
ZZEF1,"zinc finger, ZZ-type with EF-hand domain 1",17 / 986 (1.72%),"413 / 10,202","37 / 1,072 (3.45%)","30 / 1,072 (2.80%)",19,,add to survival plot
JAK3,Janus kinase 3,17 / 986 (1.72%),"279 / 10,202","55 / 1,072 (5.13%)","20 / 1,072 (1.87%)",20,Cancer Gene Census,add to survival plot
NRCAM,neuronal cell adhesion molecule,17 / 986 (1.72%),"327 / 10,202","37 / 1,072 (3.45%)","42 / 1,072 (3.92%)",19,,add to survival plot
KCNH1,"potassium channel, voltage gated eag related subfamily H, member 1",17 / 986 (1.72%),"401 / 10,202","138 / 1,072 (12.87%)","20 / 1,072 (1.87%)",18,,add to survival plot
ABCC12,"ATP-binding cassette, sub-family C (CFTR/MRP), member 12",17 / 986 (1.72%),"374 / 10,202","47 / 1,072 (4.38%)","46 / 1,072 (4.29%)",17,,add to survival plot
SHROOM2,shroom family member 2,17 / 986 (1.72%),"313 / 10,202","42 / 1,072 (3.92%)","26 / 1,072 (2.43%)",23,,add to survival plot
CPED1,cadherin-like and PC-esterase domain containing 1,17 / 986 (1.72%),"359 / 10,202","43 / 1,072 (4.01%)","38 / 1,072 (3.54%)",21,,add to survival plot
CH17-140K24.8,CH17-140K24.8,17 / 986 (1.72%),"384 / 10,202","47 / 1,072 (4.38%)","21 / 1,072 (1.96%)",18,,add to survival plot
PDE4C,"phosphodiesterase 4C, cAMP-specific",17 / 986 (1.72%),"201 / 10,202","55 / 1,072 (5.13%)","18 / 1,072 (1.68%)",17,,add to survival plot
FAM47B,"family with sequence similarity 47, member B",17 / 986 (1.72%),"394 / 10,202","21 / 1,072 (1.96%)","16 / 1,072 (1.49%)",17,,add to survival plot
IRS4,insulin receptor substrate 4,17 / 986 (1.72%),"373 / 10,202","19 / 1,072 (1.77%)","26 / 1,072 (2.43%)",18,,add to survival plot
EIF4A2,eukaryotic translation initiation factor 4A2,17 / 986 (1.72%),"227 / 10,202","127 / 1,072 (11.85%)","24 / 1,072 (2.24%)",20,Cancer Gene Census,add to survival plot
ZNF804B,zinc finger protein 804B,17 / 986 (1.72%),"530 / 10,202","40 / 1,072 (3.73%)","30 / 1,072 (2.80%)",17,,add to survival plot
BNC2,basonuclin 2,17 / 986 (1.72%),"394 / 10,202","45 / 1,072 (4.20%)","35 / 1,072 (3.26%)",17,,add to survival plot
IKBKE,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon",17 / 986 (1.72%),"194 / 10,202","160 / 1,072 (14.93%)","11 / 1,072 (1.03%)",18,,add to survival plot
UHRF1BP1L,UHRF1 binding protein 1-like,17 / 986 (1.72%),"266 / 10,202","36 / 1,072 (3.36%)","68 / 1,072 (6.34%)",18,,add to survival plot
SLC9C2,"solute carrier family 9, member C2 (putative)",17 / 986 (1.72%),"358 / 10,202","113 / 1,072 (10.54%)","33 / 1,072 (3.08%)",19,,add to survival plot
DLG5,"discs, large homolog 5 (Drosophila)",17 / 986 (1.72%),"354 / 10,202","78 / 1,072 (7.28%)","28 / 1,072 (2.61%)",18,,add to survival plot
PLXNB3,plexin B3,17 / 986 (1.72%),"314 / 10,202","67 / 1,072 (6.25%)","26 / 1,072 (2.43%)",19,,add to survival plot
KLHL1,kelch-like family member 1,17 / 986 (1.72%),"390 / 10,202","43 / 1,072 (4.01%)","44 / 1,072 (4.10%)",18,,add to survival plot
TLN2,talin 2,17 / 986 (1.72%),"513 / 10,202","36 / 1,072 (3.36%)","47 / 1,072 (4.38%)",19,,add to survival plot
SLC4A5,"solute carrier family 4 (sodium bicarbonate cotransporter), member 5",17 / 986 (1.72%),"249 / 10,202","47 / 1,072 (4.38%)","13 / 1,072 (1.21%)",18,,add to survival plot
PLCL2,phospholipase C-like 2,17 / 986 (1.72%),"264 / 10,202","79 / 1,072 (7.37%)","27 / 1,072 (2.52%)",19,,add to survival plot
CEP152,centrosomal protein 152kDa,17 / 986 (1.72%),"246 / 10,202","30 / 1,072 (2.80%)","80 / 1,072 (7.46%)",24,,add to survival plot
SAGE1,sarcoma antigen 1,17 / 986 (1.72%),"332 / 10,202","50 / 1,072 (4.66%)","18 / 1,072 (1.68%)",18,,add to survival plot
TRPA1,"transient receptor potential cation channel, subfamily A, member 1",17 / 986 (1.72%),"458 / 10,202","97 / 1,072 (9.05%)","42 / 1,072 (3.92%)",19,,add to survival plot
QRICH2,glutamine rich 2,17 / 986 (1.72%),"286 / 10,202","211 / 1,072 (19.68%)","32 / 1,072 (2.99%)",20,,add to survival plot
NEDD4L,"neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase",17 / 986 (1.72%),"206 / 10,202","34 / 1,072 (3.17%)","35 / 1,072 (3.26%)",17,,add to survival plot
CCDC144A,coiled-coil domain containing 144A,17 / 986 (1.72%),"254 / 10,202","36 / 1,072 (3.36%)","29 / 1,072 (2.71%)",22,,add to survival plot
STAT4,signal transducer and activator of transcription 4,17 / 986 (1.72%),"224 / 10,202","64 / 1,072 (5.97%)","22 / 1,072 (2.05%)",19,,add to survival plot
ZNF469,zinc finger protein 469,17 / 986 (1.72%),"224 / 10,202","41 / 1,072 (3.82%)","63 / 1,072 (5.88%)",17,,add to survival plot
CUL7,cullin 7,17 / 986 (1.72%),"248 / 10,202","74 / 1,072 (6.90%)","24 / 1,072 (2.24%)",19,,add to survival plot
MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),17 / 986 (1.72%),"384 / 10,202","126 / 1,072 (11.75%)","21 / 1,072 (1.96%)",19,,add to survival plot
CNKSR2,connector enhancer of kinase suppressor of Ras 2,17 / 986 (1.72%),"279 / 10,202","40 / 1,072 (3.73%)","16 / 1,072 (1.49%)",21,,add to survival plot
PCSK5,proprotein convertase subtilisin/kexin type 5,16 / 986 (1.62%),"404 / 10,202","29 / 1,072 (2.71%)","34 / 1,072 (3.17%)",17,,add to survival plot
CLIP1,CAP-GLY domain containing linker protein 1,16 / 986 (1.62%),"261 / 10,202","36 / 1,072 (3.36%)","84 / 1,072 (7.84%)",18,Cancer Gene Census,add to survival plot
EPHA5,EPH receptor A5,16 / 986 (1.62%),"494 / 10,202","71 / 1,072 (6.62%)","15 / 1,072 (1.40%)",16,,add to survival plot
RPTOR,"regulatory associated protein of MTOR, complex 1",16 / 986 (1.62%),"292 / 10,202","208 / 1,072 (19.40%)","43 / 1,072 (4.01%)",17,,add to survival plot
AMBRA1,autophagy/beclin-1 regulator 1,16 / 986 (1.62%),"276 / 10,202","66 / 1,072 (6.16%)","17 / 1,072 (1.59%)",17,,add to survival plot
TEX14,testis expressed 14,16 / 986 (1.62%),"374 / 10,202","194 / 1,072 (18.10%)","18 / 1,072 (1.68%)",19,,add to survival plot
ACACB,acetyl-CoA carboxylase beta,16 / 986 (1.62%),"482 / 10,202","33 / 1,072 (3.08%)","67 / 1,072 (6.25%)",18,,add to survival plot
ROBO3,"roundabout, axon guidance receptor, homolog 3 (Drosophila)",16 / 986 (1.62%),"308 / 10,202","23 / 1,072 (2.15%)","157 / 1,072 (14.65%)",16,,add to survival plot
MCM7,minichromosome maintenance complex component 7,16 / 986 (1.62%),"210 / 10,202","44 / 1,072 (4.10%)","34 / 1,072 (3.17%)",18,,add to survival plot
CHD1L,chromodomain helicase DNA binding protein 1-like,16 / 986 (1.62%),"189 / 10,202","190 / 1,072 (17.72%)","27 / 1,072 (2.52%)",15,,add to survival plot
LEPR,leptin receptor,16 / 986 (1.62%),"348 / 10,202","53 / 1,072 (4.94%)","59 / 1,072 (5.50%)",16,,add to survival plot
RBM26,RNA binding motif protein 26,16 / 986 (1.62%),"186 / 10,202","60 / 1,072 (5.60%)","30 / 1,072 (2.80%)",16,,add to survival plot
UBE4B,ubiquitination factor E4B,16 / 986 (1.62%),"303 / 10,202","23 / 1,072 (2.15%)","167 / 1,072 (15.58%)",16,,add to survival plot
CGNL1,cingulin-like 1,16 / 986 (1.62%),"270 / 10,202","24 / 1,072 (2.24%)","64 / 1,072 (5.97%)",17,,add to survival plot
INTS6,integrator complex subunit 6,16 / 986 (1.62%),"168 / 10,202","28 / 1,072 (2.61%)","96 / 1,072 (8.96%)",19,,add to survival plot
SMURF1,SMAD specific E3 ubiquitin protein ligase 1,16 / 986 (1.62%),"257 / 10,202","44 / 1,072 (4.10%)","38 / 1,072 (3.54%)",11,,add to survival plot
RIC1,RAB6A GEF complex partner 1,16 / 986 (1.62%),"208 / 10,202","60 / 1,072 (5.60%)","33 / 1,072 (3.08%)",17,,add to survival plot
ARHGAP6,Rho GTPase activating protein 6,16 / 986 (1.62%),"297 / 10,202","46 / 1,072 (4.29%)","21 / 1,072 (1.96%)",16,,add to survival plot
ANKRD36B,ankyrin repeat domain 36B,16 / 986 (1.62%),"147 / 10,202","48 / 1,072 (4.48%)","21 / 1,072 (1.96%)",17,,add to survival plot
PCDHB1,protocadherin beta 1,16 / 986 (1.62%),"311 / 10,202","47 / 1,072 (4.38%)","19 / 1,072 (1.77%)",16,,add to survival plot
PDXDC1,pyridoxal-dependent decarboxylase domain containing 1,16 / 986 (1.62%),"246 / 10,202","61 / 1,072 (5.69%)","9 / 1,072 (0.84%)",17,,add to survival plot
PREX1,"phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1",16 / 986 (1.62%),"402 / 10,202","101 / 1,072 (9.42%)","30 / 1,072 (2.80%)",17,,add to survival plot
PCDHA4,protocadherin alpha 4,16 / 986 (1.62%),"406 / 10,202","47 / 1,072 (4.38%)","20 / 1,072 (1.87%)",19,,add to survival plot
ADAMTS17,"ADAM metallopeptidase with thrombospondin type 1 motif, 17",16 / 986 (1.62%),"263 / 10,202","102 / 1,072 (9.51%)","19 / 1,072 (1.77%)",17,,add to survival plot
GTF3C1,"general transcription factor IIIC, polypeptide 1, alpha 220kDa",16 / 986 (1.62%),"452 / 10,202","51 / 1,072 (4.76%)","12 / 1,072 (1.12%)",18,,add to survival plot
ACIN1,apoptotic chromatin condensation inducer 1,16 / 986 (1.62%),"286 / 10,202","91 / 1,072 (8.49%)","23 / 1,072 (2.15%)",16,,add to survival plot
KIFC1,kinesin family member C1,16 / 986 (1.62%),"206 / 10,202","71 / 1,072 (6.62%)","28 / 1,072 (2.61%)",16,,add to survival plot
MROH5,maestro heat-like repeat family member 5,16 / 986 (1.62%),"290 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",18,,add to survival plot
ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",16 / 986 (1.62%),"446 / 10,202","36 / 1,072 (3.36%)","26 / 1,072 (2.43%)",16,,add to survival plot
SIPA1L3,signal-induced proliferation-associated 1 like 3,16 / 986 (1.62%),"421 / 10,202","77 / 1,072 (7.18%)","19 / 1,072 (1.77%)",17,,add to survival plot
PTPRM,"protein tyrosine phosphatase, receptor type, M",16 / 986 (1.62%),"377 / 10,202","34 / 1,072 (3.17%)","27 / 1,072 (2.52%)",17,,add to survival plot
PTCHD4,patched domain containing 4,16 / 986 (1.62%),"293 / 10,202","64 / 1,072 (5.97%)","29 / 1,072 (2.71%)",16,,add to survival plot
MED13L,mediator complex subunit 13-like,16 / 986 (1.62%),"379 / 10,202","34 / 1,072 (3.17%)","85 / 1,072 (7.93%)",19,,add to survival plot
TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),16 / 986 (1.62%),"222 / 10,202","113 / 1,072 (10.54%)","43 / 1,072 (4.01%)",18,,add to survival plot
ALPK1,alpha-kinase 1,16 / 986 (1.62%),"306 / 10,202","36 / 1,072 (3.36%)","41 / 1,072 (3.82%)",17,,add to survival plot
SYMPK,symplekin,16 / 986 (1.62%),"251 / 10,202","43 / 1,072 (4.01%)","57 / 1,072 (5.32%)",16,,add to survival plot
ZRANB3,"zinc finger, RAN-binding domain containing 3",16 / 986 (1.62%),"209 / 10,202","18 / 1,072 (1.68%)","47 / 1,072 (4.38%)",16,,add to survival plot
RAB11FIP1,RAB11 family interacting protein 1 (class I),16 / 986 (1.62%),"288 / 10,202","202 / 1,072 (18.84%)","46 / 1,072 (4.29%)",18,,add to survival plot
SP3,Sp3 transcription factor,16 / 986 (1.62%),"164 / 10,202","39 / 1,072 (3.64%)","27 / 1,072 (2.52%)",14,,add to survival plot
SEMA6A,"sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A",16 / 986 (1.62%),"258 / 10,202","27 / 1,072 (2.52%)","46 / 1,072 (4.29%)",17,,add to survival plot
IARS,isoleucyl-tRNA synthetase,16 / 986 (1.62%),"201 / 10,202","35 / 1,072 (3.26%)","31 / 1,072 (2.89%)",16,,add to survival plot
GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2",16 / 986 (1.62%),"279 / 10,202","30 / 1,072 (2.80%)","41 / 1,072 (3.82%)",16,,add to survival plot
ADAMTS16,"ADAM metallopeptidase with thrombospondin type 1 motif, 16",16 / 986 (1.62%),"529 / 10,202","85 / 1,072 (7.93%)","17 / 1,072 (1.59%)",17,,add to survival plot
ATP8B2,"ATPase, aminophospholipid transporter, class I, type 8B, member 2",16 / 986 (1.62%),"283 / 10,202","163 / 1,072 (15.21%)","23 / 1,072 (2.15%)",16,,add to survival plot
MORC1,MORC family CW-type zinc finger 1,16 / 986 (1.62%),"435 / 10,202","44 / 1,072 (4.10%)","21 / 1,072 (1.96%)",17,,add to survival plot
ZNF521,zinc finger protein 521,16 / 986 (1.62%),"484 / 10,202","38 / 1,072 (3.54%)","17 / 1,072 (1.59%)",19,Cancer Gene Census,add to survival plot
CROCCP2,"ciliary rootlet coiled-coil, rootletin pseudogene 2",16 / 986 (1.62%),"260 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",17,,add to survival plot
DNM3,dynamin 3,16 / 986 (1.62%),"277 / 10,202","128 / 1,072 (11.94%)","33 / 1,072 (3.08%)",20,,add to survival plot
CFAP54,cilia and flagella associated 54,16 / 986 (1.62%),"392 / 10,202","44 / 1,072 (4.10%)","55 / 1,072 (5.13%)",16,,add to survival plot
CEP95,centrosomal protein 95kDa,16 / 986 (1.62%),"144 / 10,202","231 / 1,072 (21.55%)","13 / 1,072 (1.21%)",19,,add to survival plot
L1CAM,L1 cell adhesion molecule,16 / 986 (1.62%),"349 / 10,202","68 / 1,072 (6.34%)","27 / 1,072 (2.52%)",16,,add to survival plot
PTPN14,"protein tyrosine phosphatase, non-receptor type 14",16 / 986 (1.62%),"404 / 10,202","138 / 1,072 (12.87%)","29 / 1,072 (2.71%)",18,,add to survival plot
ZBBX,"zinc finger, B-box domain containing",16 / 986 (1.62%),"356 / 10,202","131 / 1,072 (12.22%)","12 / 1,072 (1.12%)",16,,add to survival plot
PPRC1,"peroxisome proliferator-activated receptor gamma, coactivator-related 1",16 / 986 (1.62%),"270 / 10,202","33 / 1,072 (3.08%)","70 / 1,072 (6.53%)",17,,add to survival plot
RAPGEF2,Rap guanine nucleotide exchange factor (GEF) 2,16 / 986 (1.62%),"293 / 10,202","44 / 1,072 (4.10%)","49 / 1,072 (4.57%)",20,,add to survival plot
ADAMTS19,"ADAM metallopeptidase with thrombospondin type 1 motif, 19",16 / 986 (1.62%),"390 / 10,202","33 / 1,072 (3.08%)","38 / 1,072 (3.54%)",16,,add to survival plot
PCDHA8,protocadherin alpha 8,16 / 986 (1.62%),"416 / 10,202","47 / 1,072 (4.38%)","20 / 1,072 (1.87%)",16,,add to survival plot
DYRK1A,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,16 / 986 (1.62%),"267 / 10,202","76 / 1,072 (7.09%)","9 / 1,072 (0.84%)",18,,add to survival plot
PTCHD3,patched domain containing 3,16 / 986 (1.62%),"326 / 10,202","26 / 1,072 (2.43%)","26 / 1,072 (2.43%)",18,,add to survival plot
KDM4C,lysine (K)-specific demethylase 4C,16 / 986 (1.62%),"233 / 10,202","62 / 1,072 (5.78%)","31 / 1,072 (2.89%)",17,,add to survival plot
SPICE1,spindle and centriole associated protein 1,16 / 986 (1.62%),"174 / 10,202","54 / 1,072 (5.04%)","25 / 1,072 (2.33%)",17,,add to survival plot
DIAPH2,diaphanous-related formin 2,16 / 986 (1.62%),"267 / 10,202","15 / 1,072 (1.40%)","31 / 1,072 (2.89%)",17,,add to survival plot
CFAP61,cilia and flagella associated protein 61,16 / 986 (1.62%),"385 / 10,202","42 / 1,072 (3.92%)","30 / 1,072 (2.80%)",16,,add to survival plot
DSE,dermatan sulfate epimerase,16 / 986 (1.62%),"234 / 10,202","64 / 1,072 (5.97%)","58 / 1,072 (5.41%)",19,,add to survival plot
ZMYM2,"zinc finger, MYM-type 2",16 / 986 (1.62%),"241 / 10,202","77 / 1,072 (7.18%)","76 / 1,072 (7.09%)",18,Cancer Gene Census,add to survival plot
PPP1R9A,"protein phosphatase 1, regulatory subunit 9A",16 / 986 (1.62%),"339 / 10,202","41 / 1,072 (3.82%)","28 / 1,072 (2.61%)",17,,add to survival plot
GBF1,golgi brefeldin A resistant guanine nucleotide exchange factor 1,16 / 986 (1.62%),"292 / 10,202","37 / 1,072 (3.45%)","70 / 1,072 (6.53%)",16,,add to survival plot
MIB1,mindbomb E3 ubiquitin protein ligase 1,16 / 986 (1.62%),"229 / 10,202","35 / 1,072 (3.26%)","15 / 1,072 (1.40%)",19,,add to survival plot
RGPD4,RANBP2-like and GRIP domain containing 4,16 / 986 (1.62%),"496 / 10,202","38 / 1,072 (3.54%)","22 / 1,072 (2.05%)",18,,add to survival plot
KIAA0195,KIAA0195,16 / 986 (1.62%),"292 / 10,202","220 / 1,072 (20.52%)","31 / 1,072 (2.89%)",17,,add to survival plot
ADAMTS7,"ADAM metallopeptidase with thrombospondin type 1 motif, 7",16 / 986 (1.62%),"301 / 10,202","59 / 1,072 (5.50%)","20 / 1,072 (1.87%)",16,,add to survival plot
ATP11A,"ATPase, class VI, type 11A",16 / 986 (1.62%),"295 / 10,202","106 / 1,072 (9.89%)","16 / 1,072 (1.49%)",18,,add to survival plot
KTN1,kinectin 1 (kinesin receptor),16 / 986 (1.62%),"248 / 10,202","54 / 1,072 (5.04%)","35 / 1,072 (3.26%)",15,Cancer Gene Census,add to survival plot
PKD1P6,polycystic kidney disease 1 (autosomal dominant) pseudogene 6,16 / 986 (1.62%),"223 / 10,202","0 / 1,072 (0.00%)","0 / 1,072 (0.00%)",6,,add to survival plot
WDR66,WD repeat domain 66,16 / 986 (1.62%),"236 / 10,202","40 / 1,072 (3.73%)","86 / 1,072 (8.02%)",19,,add to survival plot
SCAF4,SR-related CTD-associated factor 4,16 / 986 (1.62%),"327 / 10,202","34 / 1,072 (3.17%)","26 / 1,072 (2.43%)",17,,add to survival plot
RASGRF1,Ras protein-specific guanine nucleotide-releasing factor 1,16 / 986 (1.62%),"356 / 10,202","62 / 1,072 (5.78%)","20 / 1,072 (1.87%)",22,,add to survival plot
INTS1,integrator complex subunit 1,16 / 986 (1.62%),"344 / 10,202","56 / 1,072 (5.22%)","52 / 1,072 (4.85%)",19,,add to survival plot
COL27A1,"collagen, type XXVII, alpha 1",16 / 986 (1.62%),"360 / 10,202","44 / 1,072 (4.10%)","30 / 1,072 (2.80%)",17,,add to survival plot
PLXNB2,plexin B2,16 / 986 (1.62%),"413 / 10,202","47 / 1,072 (4.38%)","48 / 1,072 (4.48%)",18,,add to survival plot
MED24,mediator complex subunit 24,16 / 986 (1.62%),"212 / 10,202","140 / 1,072 (13.06%)","52 / 1,072 (4.85%)",19,,add to survival plot
COL4A1,"collagen, type IV, alpha 1",16 / 986 (1.62%),"430 / 10,202","103 / 1,072 (9.61%)","16 / 1,072 (1.49%)",17,,add to survival plot
GUCY2F,"guanylate cyclase 2F, retinal",16 / 986 (1.62%),"290 / 10,202","22 / 1,072 (2.05%)","27 / 1,072 (2.52%)",18,,add to survival plot
FMR1,fragile X mental retardation 1,16 / 986 (1.62%),"250 / 10,202","58 / 1,072 (5.41%)","22 / 1,072 (2.05%)",17,,add to survival plot
STXBP5,syntaxin binding protein 5 (tomosyn),16 / 986 (1.62%),"217 / 10,202","62 / 1,072 (5.78%)","68 / 1,072 (6.34%)",17,,add to survival plot
RAPGEF1,Rap guanine nucleotide exchange factor (GEF) 1,16 / 986 (1.62%),"251 / 10,202","49 / 1,072 (4.57%)","37 / 1,072 (3.45%)",17,,add to survival plot
ABCC4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4",16 / 986 (1.62%),"278 / 10,202","94 / 1,072 (8.77%)","19 / 1,072 (1.77%)",16,,add to survival plot
TOPAZ1,testis and ovary specific PAZ domain containing 1,16 / 986 (1.62%),"132 / 10,202","20 / 1,072 (1.87%)","118 / 1,072 (11.01%)",18,,add to survival plot
ITGA1,"integrin, alpha 1",16 / 986 (1.62%),"223 / 10,202","31 / 1,072 (2.89%)","57 / 1,072 (5.32%)",18,,add to survival plot
KCNU1,"potassium channel, subfamily U, member 1",16 / 986 (1.62%),"390 / 10,202","160 / 1,072 (14.93%)","54 / 1,072 (5.04%)",16,,add to survival plot
MYH2,"myosin, heavy chain 2, skeletal muscle, adult",16 / 986 (1.62%),"692 / 10,202","12 / 1,072 (1.12%)","31 / 1,072 (2.89%)",17,,add to survival plot
DDX5,DEAD (Asp-Glu-Ala-Asp) box helicase 5,16 / 986 (1.62%),"149 / 10,202","232 / 1,072 (21.64%)","13 / 1,072 (1.21%)",19,Cancer Gene Census,add to survival plot
TP53BP2,tumor protein p53 binding protein 2,16 / 986 (1.62%),"245 / 10,202","154 / 1,072 (14.37%)","20 / 1,072 (1.87%)",16,,add to survival plot
MAT2A,"methionine adenosyltransferase II, alpha",16 / 986 (1.62%),"131 / 10,202","51 / 1,072 (4.76%)","17 / 1,072 (1.59%)",15,,add to survival plot
ITGA11,"integrin, alpha 11",16 / 986 (1.62%),"259 / 10,202","42 / 1,072 (3.92%)","36 / 1,072 (3.36%)",17,,add to survival plot
RREB1,ras responsive element binding protein 1,16 / 986 (1.62%),"325 / 10,202","88 / 1,072 (8.21%)","59 / 1,072 (5.50%)",16,,add to survival plot
TDRD5,tudor domain containing 5,16 / 986 (1.62%),"375 / 10,202","109 / 1,072 (10.17%)","33 / 1,072 (3.08%)",16,,add to survival plot
CDH6,"cadherin 6, type 2, K-cadherin (fetal kidney)",16 / 986 (1.62%),"389 / 10,202","48 / 1,072 (4.48%)","12 / 1,072 (1.12%)",17,,add to survival plot
ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",16 / 986 (1.62%),"234 / 10,202","70 / 1,072 (6.53%)","26 / 1,072 (2.43%)",17,,add to survival plot
HEATR5B,HEAT repeat containing 5B,16 / 986 (1.62%),"338 / 10,202","42 / 1,072 (3.92%)","16 / 1,072 (1.49%)",16,,add to survival plot
GPRASP2,G protein-coupled receptor associated sorting protein 2,16 / 986 (1.62%),"214 / 10,202","12 / 1,072 (1.12%)","28 / 1,072 (2.61%)",17,,add to survival plot
OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",16 / 986 (1.62%),"233 / 10,202","25 / 1,072 (2.33%)","74 / 1,072 (6.90%)",19,,add to survival plot
ITSN1,intersectin 1 (SH3 domain protein),16 / 986 (1.62%),"345 / 10,202","53 / 1,072 (4.94%)","17 / 1,072 (1.59%)",19,,add to survival plot
DLG2,"discs, large homolog 2 (Drosophila)",16 / 986 (1.62%),"465 / 10,202","110 / 1,072 (10.26%)","57 / 1,072 (5.32%)",19,,add to survival plot
PAXBP1,PAX3 and PAX7 binding protein 1,16 / 986 (1.62%),"240 / 10,202","41 / 1,072 (3.82%)","17 / 1,072 (1.59%)",17,,add to survival plot
FANCI,"Fanconi anemia, complementation group I",16 / 986 (1.62%),"243 / 10,202","88 / 1,072 (8.21%)","20 / 1,072 (1.87%)",17,,add to survival plot
GTF2IRD2,GTF2I repeat domain containing 2,16 / 986 (1.62%),"191 / 10,202","48 / 1,072 (4.48%)","25 / 1,072 (2.33%)",16,,add to survival plot
